{"sample_id": "takeoff41_001", "track": "open_ended", "split": "holdout", "question": "What are the recommended indications and glucose infusion rates (GIR) for initiating parenteral nutrition in a critically ill adult patient to avoid refeeding syndrome?", "reference_answer": "Parenteral nutrition (PN) is indicated when enteral nutrition is contraindicated or insufficient. To prevent refeeding syndrome, clinicians should initiate PN with a glucose infusion rate (GIR) of 1-2 mg/kg/min or approximately 100-150 grams of dextrose per day, while monitoring phosphorus, magnesium, and potassium levels closely.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 129, "relevance_score": 33, "raw_id": 1}}
{"sample_id": "takeoff41_002", "track": "open_ended", "split": "holdout", "question": "What clinical strategy is recommended to reduce cholestasis in patients receiving parenteral nutrition?", "reference_answer": "Initiation of enteral feedings is considered beneficial in reducing cholestasis, while avoiding excessive lipid emulsions (>40% of calories) and maintaining a glucose infusion rate (GIR) below 15 mg/kg/min are also key management principles.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 981, "relevance_score": 29, "raw_id": 2}}
{"sample_id": "takeoff41_003", "track": "open_ended", "split": "holdout", "question": "In the context of neonatal and pediatric parenteral nutrition calculations, what clinical metric does the abbreviation GIR represent and why is it monitored?", "reference_answer": "GIR stands for Glucose Infusion Rate. It is measured in mg/kg/min and is monitored to ensure the rate of intravenous glucose administration does not exceed the patient's metabolic capacity to prevent hyperglycemia and hepatic steatosis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1225, "relevance_score": 27, "raw_id": 3}}
{"sample_id": "takeoff41_004", "track": "open_ended", "split": "holdout", "question": "In the management of Parenteral Nutrition (PN), what is the maximum recommended glucose infusion rate (GIR) to prevent hepatic steatosis and hyperglycemia in stable adult patients?", "reference_answer": "The maximum recommended glucose infusion rate for stable adult patients receiving parenteral nutrition is generally 4 to 5 mg/kg/minute (or approximately 20-25 kcal/kg/day from carbohydrates) to avoid overfeeding and metabolic complications.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 13, "relevance_score": 25, "raw_id": 4}}
{"sample_id": "takeoff41_005", "track": "open_ended", "split": "holdout", "question": "What specific parenteral nutrition formulation strategies and electrolyte ranges are recommended to minimize bone loss and prevent hypercalciuria in patients on long-term therapy?", "reference_answer": "To prevent osteoporosis, the PN formulation should provide 10–15 mEq/d of calcium and 20–40 mmol/d of phosphorus. Strategies include avoiding high doses of protein and excessive sodium, maintaining adequate magnesium and copper intake, treating metabolic acidosis, minimizing aluminum contamination (e.g., using sodium phosphate over potassium phosphate), and avoiding the addition of heparin.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 357, "relevance_score": 25, "raw_id": 5}}
{"sample_id": "takeoff41_006", "track": "open_ended", "split": "holdout", "question": "What is the recommended glucose infusion rate (GIR) limit to prevent hepatic steatosis and hyperglycemia in adult patients receiving Parenteral Nutrition (PN)?", "reference_answer": "The maximum recommended glucose infusion rate for a stable adult patient receiving PN is 4 to 5 mg/kg/minute (or approximately 20-25 kcal/kg/day from carbohydrates). Exceeding a GIR of 7 mg/kg/min is associated with increased risk of CO2 production, hyperglycemia, and hepatic lipogenesis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 56, "relevance_score": 25, "raw_id": 6}}
{"sample_id": "takeoff41_007", "track": "open_ended", "split": "holdout", "question": "What are the specific blood glucose thresholds and subsequent adjustments required for pediatric patients undergoing cyclic parenteral nutrition (PN) to address hyperglycemia and hypoglycemia?", "reference_answer": "Blood glucose levels >150 mg/dL require a decrease in dextrose amount or lengthening of the cyclic infusion to decrease the glucose infusion rate (GIR). Levels <60 mg/dL or symptoms of hypoglycemia require a longer taper period at the end of the cyclic PN.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1196, "relevance_score": 25, "raw_id": 7}}
{"sample_id": "takeoff41_008", "track": "open_ended", "split": "holdout", "question": "What is the recommended glucose infusion rate (GIR) limit to prevent overfeeding and hyperglycemia in adult patients receiving Parenteral Nutrition (PN)?", "reference_answer": "For adult patients, the maximum recommended glucose infusion rate is 4 to 5 mg/kg/min (approximately 20-25 kcal/kg/day from carbohydrates) to avoid complications such as hyperglycemia, hepatic steatosis, and excessive carbon dioxide production.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 109, "relevance_score": 25, "raw_id": 8}}
{"sample_id": "takeoff41_009", "track": "open_ended", "split": "holdout", "question": "A patient on parenteral nutrition presents with neurological symptoms including confusion, tremors, and seizures, while maintaining normal serum sodium (138 mmol/L), glucose (94 mg/dL), and calcium (9.0 mg/dL) levels. Which metabolic complication associated with refeeding or PN mismanagement is most likely responsible for these symptoms?", "reference_answer": "The clinical presentation of confusion, tremors, and seizures in a PN patient with otherwise normal electrolytes and glucose is most characteristic of severe hypophosphatemia. Hypophosphatemia is a hallmark of Refeeding Syndrome and can lead to significant neurological dysfunction, respiratory failure, and cardiac arrhythmias by depleting adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (2,3-DPG).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 93, "relevance_score": 25, "raw_id": 9}}
{"sample_id": "takeoff41_010", "track": "open_ended", "split": "holdout", "question": "What are the primary clinical indications and the standard glucose infusion rate (GIR) limit for initiating parenteral nutrition in a stable neonate to avoid metabolic complications?", "reference_answer": "Parenteral nutrition is indicated when enteral feeding is impossible, inadequate, or contraindicated; for stable neonates, the maximum recommended glucose infusion rate (GIR) is typically 12 to 18 mg/kg/min to prevent hyperglycemia and hepatic steatosis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 107, "relevance_score": 24, "raw_id": 10}}
{"sample_id": "takeoff41_011", "track": "open_ended", "split": "holdout", "question": "What is the recommended glucose infusion rate (GIR) for an adult receiving Parenteral Nutrition to prevent hyperglycemia and hepatic steatosis?", "reference_answer": "The maximum recommended glucose infusion rate for an adult is 4 to 5 mg/kg/minute (or 20-25 kcal/kg/day from carbohydrates) to avoid overfeeding and metabolic complications.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 373, "relevance_score": 24, "raw_id": 11}}
{"sample_id": "takeoff41_012", "track": "open_ended", "split": "holdout", "question": "What is the recommended glucose infusion rate (GIR) to prevent overfeeding and hyperglycemia in adult patients receiving total parenteral nutrition?", "reference_answer": "The maximum recommended glucose infusion rate for adult patients is typically 4 to 5 mg/kg/min to avoid complications such as hyperglycemia, lipogenesis, and increased CO2 production.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 134, "relevance_score": 23, "raw_id": 12}}
{"sample_id": "takeoff41_013", "track": "open_ended", "split": "holdout", "question": "How should the risk of refeeding syndrome be managed when initiating nutritional support in a severely malnourished patient?", "reference_answer": "Management of refeeding syndrome risk involves identifying high-risk patients (e.g., BMI <16 kg/m², unintentional weight loss >15% in 3-6 months), restricting initial caloric intake to 10-20 kcal/kg or roughly 50% of estimated requirements, and closely monitoring serum phosphorus, potassium, and magnesium. Electrolytes should be replaced aggressively before and during the escalation of nutritional intake over 4 to 7 days.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 87, "relevance_score": 23, "raw_id": 13}}
{"sample_id": "takeoff41_014", "track": "open_ended", "split": "holdout", "question": "What are the carbohydrate and lipid administration guidelines for infants in the immediate postoperative period following cardiac surgery, specifically regarding the glucose infusion rate (GIR)?", "reference_answer": "Carbohydrates should comprise 40%–60% of total daily calories, with a glucose infusion rate (GIR) initiated at 4–8 mg/kg/min and advanced to a maximum of 12–14 mg/kg/min. Lipids should be provided at 1.5–3 g/kg/d, though intake may be limited by cholestasis or hypertriglyceridemia.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 253, "relevance_score": 23, "raw_id": 14}}
{"sample_id": "takeoff41_015", "track": "open_ended", "split": "holdout", "question": "In neonatal parenteral nutrition, what is the optimal calcium-to-phosphorus ratio for maximizing bone mineralization and minimizing urinary losses?", "reference_answer": "The optimal ratio is 1.7 mg of calcium to 1 mg of phosphorus, which is particularly critical for preterm infants to mimic the accretion rates that occur during the last 6 weeks of gestation.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1182, "relevance_score": 23, "raw_id": 15}}
{"sample_id": "takeoff41_016", "track": "open_ended", "split": "holdout", "question": "What is the maximum osmolarity recommended for parenteral nutrition infused via peripheral vascular access, and what equation is used to approximate the osmolarity of a PN solution?", "reference_answer": "The final osmolarity must be less than 900 mOsm/L for peripheral access; the approximate osmolarity is calculated as [Dextrose g/L × 5] + [amino acid g/L × 10] + [(sodium + potassium + calcium + magnesium mEq/L) × 2].", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 190, "relevance_score": 23, "raw_id": 16}}
{"sample_id": "takeoff41_017", "track": "open_ended", "split": "holdout", "question": "What is the recommended glucose infusion rate (GIR) to prevent hyperglycemia and hepatic steatosis in neonates receiving Parenteral Nutrition?", "reference_answer": "The recommended maximum glucose infusion rate for neonates is typically 12 to 18 mg/kg/min, starting at a lower rate of 4 to 8 mg/kg/min and titrating up to avoid metabolic complications such as hyperglycemia or excessive lipid deposition in the liver.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 51, "relevance_score": 23, "raw_id": 17}}
{"sample_id": "takeoff41_018", "track": "open_ended", "split": "holdout", "question": "How should the risk of Refeeding Syndrome be managed when initiating nutrition support in a severely malnourished patient?", "reference_answer": "Management involves identifying high-risk patients (e.g., BMI <15 kg/m², unintentional weight loss >15% in 3-6 months), starting caloric intake at 10-25% of the goal (typically 10-15 kcal/kg), slowly advancing over 3-5 days, and monitoring/supplementing electrolytes including phosphorus, potassium, magnesium, and thiamine prior to and during the initiation of feeding.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 127, "relevance_score": 23, "raw_id": 18}}
{"sample_id": "takeoff41_019", "track": "open_ended", "split": "holdout", "question": "According to ASPEN guidelines, what are the daily parenteral nutrition dosing ranges for calcium and phosphorus in preterm neonates, and why is it impossible to match in utero accretion rates?", "reference_answer": "The ASPEN recommended parenteral dosing for preterm neonates is 2–4 mEq/kg/d of calcium and 1–2 mmol/kg/d of phosphorus. It is impossible to match in utero accretion rates (6–7.5 mEq/kg/d of calcium and 2.3–2.7 mmol/kg/d of phosphorus) because solubility limits within parenteral nutrition (PN) solutions prohibit supplying those higher mineral levels.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1151, "relevance_score": 23, "raw_id": 19}}
{"sample_id": "takeoff41_020", "track": "open_ended", "split": "holdout", "question": "How is the target caloric requirement calculated for a patient at risk for refeeding syndrome during the initial 24–48 hours of nutritional support?", "reference_answer": "For patients at high risk for refeeding syndrome, it is recommended to initiate nutritional support at a conservative 10–20 kcal/kg per day or approximately 25% of the estimated caloric goal for the first 24–48 hours, while closely monitoring and replacing electrolytes such as phosphorus, potassium, and magnesium.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 83, "relevance_score": 22, "raw_id": 20}}
{"sample_id": "takeoff41_021", "track": "open_ended", "split": "holdout", "question": "What are the recommended initial and advanced glucose infusion rates (GIR) for carbohydrates supplied via parenteral nutrition in neonates?", "reference_answer": "Dextrose is initiated at a minimum glucose infusion rate (GIR) of 5–8 mg/kg/min and is gradually advanced to a goal of 12–15 mg/kg/min, depending on the infant's carbohydrate tolerance.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 195, "relevance_score": 22, "raw_id": 21}}
{"sample_id": "takeoff41_022", "track": "open_ended", "split": "holdout", "question": "In the management of Refeeding Syndrome, what are the specific biochemical threshold criteria and the recommended initial caloric intake to prevent cardiac and neurological complications?", "reference_answer": "Refeeding Syndrome is characterized by acute intracellular shifts of electrolytes, specifically phosphorus (<0.65 mmol/L), potassium, and magnesium, following carbohydrate reintroduction. To prevent complications, initial caloric intake should be restricted to 10-15 kcal/kg/day, or as low as 5-10 kcal/kg/day in extreme cases, while ensuring adequate thiamine supplementation (typically 200-300 mg daily) prior to starting feeds.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 120, "relevance_score": 22, "raw_id": 22}}
{"sample_id": "takeoff41_023", "track": "open_ended", "split": "holdout", "question": "What is the clinical justification for initiating glucose infusion rates at approximately 4-6 mg/kg/min in neonatal parenteral nutrition?", "reference_answer": "Initiating GIR at 4-6 mg/kg/min supports the metabolic needs of the neonate without causing excessive metabolic stress, allowing for cautious advancement based on patient tolerance.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 234, "relevance_score": 22, "raw_id": 23}}
{"sample_id": "takeoff41_024", "track": "open_ended", "split": "holdout", "question": "According to the guidelines for Ketogenic Total Parenteral Nutrition (TPN), how should lipid infusions be managed and what specific metabolic factors must be accounted for in ratio calculations?", "reference_answer": "Lipid infusions should start at 0.5–1 mL/kg/h and advance by 0.5–1 mL/kg/h daily until the highest possible rate is achieved. When calculating the ketogenic ratio, the carbohydrate content of glycerol from the lipids must be included. Additionally, labs including triglycerides, electrolytes, and bicarbonate should be monitored daily, and carnitine supplementation is recommended.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 415, "relevance_score": 22, "raw_id": 24}}
{"sample_id": "takeoff41_025", "track": "open_ended", "split": "holdout", "question": "What are the comparative elemental calcium contents and recommended administration routes for 10% calcium gluconate versus 10% calcium chloride?", "reference_answer": "Calcium gluconate (10%) provides 92 mg (4.65 mEq) of elemental calcium per 1000 mg and can be administered via peripheral or central routes. Calcium chloride (10%) provides 272 mg (13.6 mEq) of elemental calcium per 1000 mg and should be administered via a central venous catheter, particularly in nonemergent situations, to reduce the risk of injury if extravasated.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 157, "relevance_score": 22, "raw_id": 25}}
{"sample_id": "takeoff41_026", "track": "open_ended", "split": "holdout", "question": "What are the standard compositions and infusion rates for Intradialytic Parenteral Nutrition (IDPN), and what is the primary purpose of providing minimal energy intake during this therapy?", "reference_answer": "IDPN is typically composed of concentrated dextrose (maintaining a glucose infusion rate of 5 to 9 mg/kg/min), amino acids (providing approximately 1.3 g protein/kg per treatment), and separate 20% intravenous fat emulsion (IVFE). The purpose of the energy provided is to maximize protein utilization.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 699, "relevance_score": 22, "raw_id": 26}}
{"sample_id": "takeoff41_027", "track": "open_ended", "split": "holdout", "question": "How should the risk of refeeding syndrome be managed in severely malnourished patients initiating enteral or parenteral nutrition?", "reference_answer": "Management includes identifying at-risk patients (e.g., BMI <15 kg/m²), initiating nutrition at 10-20 kcal/kg/day or 50% of requirements, and closely monitoring/supplementing electrolytes, specifically phosphate, magnesium, potassium, and thiamine, before and during the first 5-7 days of feeding.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 27, "relevance_score": 22, "raw_id": 27}}
{"sample_id": "takeoff41_028", "track": "open_ended", "split": "holdout", "question": "According to the PN - Trace Element Daily Needs table, what are the specific micronutrient requirements for Copper and Manganese in preterm infants weighing less than 3 kg?", "reference_answer": "For preterm infants <3 kg, the daily parenteral nutrition requirements are 20 mcg/kg of Copper (CU) and 1 mcg/kg of Manganese (MN).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 350, "relevance_score": 22, "raw_id": 28}}
{"sample_id": "takeoff41_029", "track": "open_ended", "split": "holdout", "question": "How does the advancement of intravenous dextrose infusion rates (GIR) typically differ between neonates and older pediatric patients in clinical nutrition practice?", "reference_answer": "Neonate guidelines often recommend a starting glucose infusion rate (GIR) of 4-8 mg/kg/min with cautious daily increments of 1-3 mg/kg/min, whereas older children may have different target advancing rates based on metabolic demand and total caloric requirements as detailed in standardized clinical nutrition tables.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1144, "relevance_score": 22, "raw_id": 29}}
{"sample_id": "takeoff41_030", "track": "open_ended", "split": "holdout", "question": "What are the recommended goal ranges for dextrose infusion rates (GIR) and protein intake for children aged 1 to 10 years receiving parenteral nutrition?", "reference_answer": "For children aged 1 to 10 years, the goal glucose infusion rate (GIR) is 8–10 mg/kg/min and the goal protein intake is 1.5–2.5 g/kg/d.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 155, "relevance_score": 22, "raw_id": 30}}
{"sample_id": "takeoff41_031", "track": "open_ended", "split": "holdout", "question": "According to the Pediatric Renal Nutrition Taskforce guidelines provided in Exhibit 19-1, what is the protocol for using sodium polystyrene sulfonate (SPS) to reduce the potassium content of enteral formula or expressed human milk?", "reference_answer": "The protocol involves adding SPS to the liquid at a suggested starting dose of 0.4–1.5 g/100 mL (or 0.25–1 g/mmol K), allowing it to precipitate for a minimum of 30 minutes in a refrigerator, and then decanting the liquid to separate it from the residue at the bottom. As an exchange resin, this process may increase levels of sodium, aluminum, iron, sulfur, and pH, while decreasing calcium, zinc, copper, phosphorus, manganese, and magnesium.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 377, "relevance_score": 21, "raw_id": 31}}
{"sample_id": "takeoff41_032", "track": "open_ended", "split": "holdout", "question": "What clinical criteria define refined 'refeeding syndrome' risk, and what are the initial electrolyte monitoring requirements?", "reference_answer": "Refeeding syndrome risk is high in patients with a BMI < 16 kg/m2, unintentional weight loss > 15% in 3-6 months, or little to no nutritional intake for > 10 days. Management requires monitoring and replacing phosphorus, potassium, and magnesium, along with starting thiamine (200-300mg daily) prior to and during the first 10 days of nutritional repletion.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 15, "relevance_score": 21, "raw_id": 32}}
{"sample_id": "takeoff41_033", "track": "open_ended", "split": "holdout", "question": "What clinical interventions are recommended if a patient experiences hyperglycemia or hypoglycemia during cyclic PN infusion based on the provided text?", "reference_answer": "If blood glucose is greater than 150 mg/dL, consider decreasing the glucose infusion rate (GIR). If hypoglycemia occurs when the patient is off PN, consider increasing the PN hours or extending the tapering period at the end of the cyclic infusion.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 175, "relevance_score": 21, "raw_id": 33}}
{"sample_id": "takeoff41_034", "track": "open_ended", "split": "holdout", "question": "In neonatal clinical practice, what is the minimum protein dose required to prevent a negative nitrogen balance and reduce the risk of hyperkalemia, and how does protein dosing differ between preterm and term neonates?", "reference_answer": "A protein dose of 1 g/kg/d is sufficient to prevent negative nitrogen balance and minimize hyperkalemia risk. For neonates receiving 'starter PN', preterm neonates are dosed as high as 4 g/kg/d to prevent losses, while term neonates begin at 2-3 g/kg/d with a target goal of 2.5-3 g/kg/d.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 195, "relevance_score": 20, "raw_id": 34}}
{"sample_id": "takeoff41_035", "track": "open_ended", "split": "holdout", "question": "According to the parenteral nutrition guidelines provided, what are the specific protein requirements for pediatric patients aged 0-2 years and preterm infants?", "reference_answer": "Protein intake should be optimized at 1.5-2x the RDA/DRI. Specifically, patients aged 0-2 years should receive 3-4 g/kg, and preterm infants should receive 3.5-4 g/kg.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 257, "relevance_score": 20, "raw_id": 35}}
{"sample_id": "takeoff41_036", "track": "open_ended", "split": "holdout", "question": "What are the recommended glucose infusion rates (GIR) for pediatric patients on parenteral nutrition, and what is the potential metabolic consequence of exceeding the patient's oxidative capacity?", "reference_answer": "Glucose is the primary energy source in PN, with infusion rates typically varying by age and diagnosis. While rates >10 mg/kg/min may result in the conversion of glucose to fat (fat deposition), anecdotal evidence suggests infants and young children may tolerate rates up to 15 mg/kg/min.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 809, "relevance_score": 20, "raw_id": 36}}
{"sample_id": "takeoff41_037", "track": "open_ended", "split": "holdout", "question": "In pediatric patients, what is the recommended starting range for potassium supplementation in parenteral nutrition solutions, and which medications are associated with the development of hypokalemia?", "reference_answer": "Supplementation in parenteral nutrition (PN) should start at approximately 2 to 4 mEq/kg. Medications associated with hypokalemia include loop diuretics, thiazide diuretics, high-dose glucocorticoids, phenolphthalein, sodium polystyrene sulfonate, sorbitol, beta-2-adrenergic agonists, tocolytic agents, theophylline, caffeine, and insulin/dextrose.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 225, "relevance_score": 20, "raw_id": 37}}
{"sample_id": "takeoff41_038", "track": "open_ended", "split": "holdout", "question": "What are the monitoring protocols and reference ranges for serum Zinc and Copper in preterm infants as specified in the lab guidelines?", "reference_answer": "For infants <33 weeks gestation or <1500 g, Zinc should be checked at birth, 1 month, and monthly until 37 weeks PMA (preterm range 74-146 mcg/dL). Copper levels should be obtained for cholestatic infants on TPN >1 month (preterm range 30-40 mcg/dL).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 502, "relevance_score": 20, "raw_id": 38}}
{"sample_id": "takeoff41_039", "track": "open_ended", "split": "holdout", "question": "According to the parenteral nutrition section of the document, what are the specific units used to document and measure the Glucose Infusion Rate (GIR)?", "reference_answer": "The Glucose Infusion Rate (GIR) is measured in mg/kg/min.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1231, "relevance_score": 20, "raw_id": 39}}
{"sample_id": "takeoff41_040", "track": "open_ended", "split": "holdout", "question": "In the ASPEN recommendations for commercially available multi-trace element products, what were the primary changes suggested regarding the concentrations of manganese and chromium in adult formulations?", "reference_answer": "ASPEN recommended reducing the daily doses of manganese and chromium in multi-trace element products to prevent potential toxicity, specifically suggesting manganese doses be reduced to 55 mcg/day and chromium to 0.8–15 mcg/day, reflecting concerns over accumulation in long-term parenteral nutrition patients.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 446, "relevance_score": 20, "raw_id": 40}}
{"sample_id": "takeoff41_041", "track": "open_ended", "split": "holdout", "question": "Why might a clinician need to reduce the initial dose of calcium in a parenteral nutrition (PN) admixture when treating a patient at risk for refeeding syndrome?", "reference_answer": "An initial reduction in calcium dosing may be required to accommodate increased doses of phosphate while remaining within calcium-phosphate solubility limits during PN compounding.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 317, "relevance_score": 20, "raw_id": 41}}
{"sample_id": "takeoff41_042", "track": "open_ended", "split": "holdout", "question": "How does the administration of Propofol impact the caloric and lipid intake of a pediatric patient, and what adjustments should be made to parenteral nutrition if lipids are being co-administered?", "reference_answer": "Propofol provides a significant caloric density of 1.1 kcal/ml and lipids at 1g/ml because it is formulated in a 10% lipid solution. To prevent overfeeding and hypertriglyceridemia during prolonged infusions, IV lipids in parenteral nutrition (PN) should be held while the patient is receiving propofol.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 405, "relevance_score": 20, "raw_id": 42}}
{"sample_id": "takeoff41_043", "track": "open_ended", "split": "holdout", "question": "What are the ASPEN-recommended daily parenteral nutrition doses for calcium and phosphorus in preterm neonates?", "reference_answer": "For preterm neonates, the recommended daily dose of calcium is 2–4 mEq/kg and the recommended dose for phosphorus is 1–2 mmol/kg (equivalent to 3.1–6.2 mg/kg).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 196, "relevance_score": 20, "raw_id": 43}}
{"sample_id": "takeoff41_044", "track": "open_ended", "split": "holdout", "question": "What is the biological role of carnitine in nutrition, which patient populations are considered to have an essential need for it, and what is the standard dosing range in parenteral nutrition?", "reference_answer": "Carnitine transports fatty acids into the mitochondria. It is considered essential for patients with renal disease on dialysis, liver disease, preterm infants, metabolic disorders, and those dependent on PN. The dose ranges from 5 to 20 mg/kg/d.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 165, "relevance_score": 20, "raw_id": 44}}
{"sample_id": "takeoff41_045", "track": "open_ended", "split": "holdout", "question": "According to the provided clinical data, what is the recommended protein-to-energy ratio (g/100 kcal) for a preterm infant receiving parenteral nutrition when the total energy expenditure is 60 kcal/kg/d?", "reference_answer": "When the energy expenditure is 60 kcal/kg/d, the recommended protein/energy ratio for parenteral nutrition is 3.9 g/100 kcal (or 3.8 g/100 kcal depending on the specific accretion requirements in the 60 energy expenditure column).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1010, "relevance_score": 20, "raw_id": 45}}
{"sample_id": "takeoff41_046", "track": "open_ended", "split": "holdout", "question": "What are the recommended guidelines for the initiation of Parenteral Nutrition (PN) and the volume-based protocol for advancing Enteral Nutrition (EN) in preterm infants?", "reference_answer": "Parenteral nutrition should be initiated within 24 hours of birth if goal enteral feeds are not possible. Enteral feeds should begin at trophic rates of 12–24 mL/kg/d and advance in increments of 18–30 mL/kg/day based on tolerance, with a target volume of 150–180 mL/kg/d.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1009, "relevance_score": 20, "raw_id": 46}}
{"sample_id": "takeoff41_047", "track": "open_ended", "split": "holdout", "question": "Describe the transition criteria and standard nutrient profile for preterm transitional formulas used after hospital discharge.", "reference_answer": "Infants typically transition to these formulas at a weight of 1800–2000 g or a gestational age of 34 weeks, continuing until 6 to 9 months of age. These formulas have a standard caloric concentration of 22 kcal/oz and a protein content of 2.8 g/100 kcal, providing higher calcium and phosphorus levels than standard term formulas to meet requirements without additional supplementation.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 313, "relevance_score": 19, "raw_id": 47}}
{"sample_id": "takeoff41_048", "track": "open_ended", "split": "holdout", "question": "What is the recommended protocol for treating refractory hypocalcemia with a continuous IV infusion of elemental calcium?", "reference_answer": "Treatment begins with an initial IV dose of 100–300 mg of elemental calcium (via 1 g calcium chloride or 3 g calcium gluconate) over 5–10 minutes. If ionized calcium is not normalized, a continuous IV infusion of elemental calcium at 0.25–2 mg/kg/h via central access is recommended, with ionized calcium monitoring every 1–4 hours. Once normalized, a maintenance infusion of 0.3–0.5 mg/kg/h should be titrated to desired concentrations.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 157, "relevance_score": 19, "raw_id": 48}}
{"sample_id": "takeoff41_049", "track": "open_ended", "split": "holdout", "question": "Compare the use of calcium gluconate and calcium chloride in treating hyperkalemia, including the standard dosing for gluconate and the potential drawback of peripheral administration for chloride.", "reference_answer": "Calcium gluconate is administered at a dose of 1–2 g (4.65–9.3 mEq of calcium) IV over 5–10 minutes and can be repeated in 5 minutes if ECG abnormalities persist. While calcium chloride provides more calcium per gram (1 g = 13.6 mEq), it can cause venous irritation if administered through a peripheral line.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 109, "relevance_score": 19, "raw_id": 49}}
{"sample_id": "takeoff41_050", "track": "open_ended", "split": "holdout", "question": "In patients requiring phosphorus replacement, under what circumstances is sodium phosphate preferred over potassium phosphate, and what electrolyte/volume factors require specialized evaluation before its use?", "reference_answer": "Sodium phosphate is preferred when patients do not have concurrent hypokalemia, primarily because it contains approximately one-third the amount of aluminum as potassium phosphate, which is especially critical in neonates. However, patients experiencing volume overload, hypernatremia, or those requiring sodium restriction must be evaluated for complications before use due to the product's sodium content (approx 4 mEq per 1 mL/3 mmol phosphate).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 181, "relevance_score": 19, "raw_id": 50}}
{"sample_id": "takeoff41_051", "track": "open_ended", "split": "holdout", "question": "According to clinical observations, what specific neonatal complications are associated with preterm infants weighing less than 1.5 kg who exhibit elevated plasma vitamin E levels?", "reference_answer": "Preterm infants born at <1.5 kg with elevated plasma vitamin E (mean of 5.1 mg/dL) show an increased incidence of sepsis and necrotizing enterocolitis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 201, "relevance_score": 19, "raw_id": 51}}
{"sample_id": "takeoff41_052", "track": "open_ended", "split": "holdout", "question": "Based on Abrams (2013), what are the calcium and vitamin D requirements for enterally fed preterm infants to support bone mineralization?", "reference_answer": "Enterally fed preterm infants require significantly higher amounts of calcium (120–200 mg/kg/day) and phosphorus (60–140 mg/kg/day) compared to term infants, along with a Vitamin D intake typically ranging from 200 to 400 IU/day, though some guidelines suggest up to 1000 IU/day depending on the infant's weight and clinical status.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 503, "relevance_score": 19, "raw_id": 52}}
{"sample_id": "takeoff41_053", "track": "open_ended", "split": "holdout", "question": "What are the electrolyte values for Sodium, Potassium, and Calcium per 100 kcal of Modulen®, and what is the formula's total osmolarity?", "reference_answer": "Modulen® provides 50 mg (2.1 mEq) of Sodium, 158 mg (4.2 mEq) of Potassium, and 125 mg (6.25 mEq) of Calcium per 100 kcal. The formula has an osmolarity of 415 mOsm/kg H2O.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 304, "relevance_score": 19, "raw_id": 53}}
{"sample_id": "takeoff41_054", "track": "open_ended", "split": "holdout", "question": "According to the provided clinical nutrition data, what is the required mixing protocol and resulting caloric density for the 5 mL liquid vial format of Human Milk Fortifier?", "reference_answer": "One 5 mL vial mixed with 50 mL of breast milk results in a caloric density of 22 kcal/oz; mixing one 5 mL vial with 25 mL of breast milk results in 24 kcal/oz. This product is indicated for preterm infants only.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 104, "relevance_score": 19, "raw_id": 54}}
{"sample_id": "takeoff41_055", "track": "open_ended", "split": "holdout", "question": "What precautions should clinicians take when using multi-nutrient human milk fortifiers (HMFs) or preterm formulas for term infants consuming more than 500 mL per day?", "reference_answer": "When feeding volumes exceed 500 mL/d, multi-nutrient HMFs or formulas designed for preterm infants should be used with caution, specifically monitoring for excessive intake of protein and certain micronutrients.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 285, "relevance_score": 18, "raw_id": 55}}
{"sample_id": "takeoff41_056", "track": "open_ended", "split": "holdout", "question": "In patients receiving Parenteral Nutrition (PN), what is the threshold for blood glucose levels required to minimize the risk of infectious complications, and how often should glucose be monitored during the initial phase?", "reference_answer": "The target blood glucose range for patients on PN is typically 140–180 mg/dL (7.8–10.0 mmol/L). During the initial infusion or until the patient is stable, capillary blood glucose should be monitored every 2 to 6 hours to prevent hyperglycemia and associated risks of catheter-related bloodstream infections.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 20, "relevance_score": 18, "raw_id": 56}}
{"sample_id": "takeoff41_057", "track": "open_ended", "split": "holdout", "question": "According to the guidelines for parenteral nutrition, what are the daily sodium and potassium requirements for preterm infants?", "reference_answer": "For preterm infants, the recommended daily provision for both Sodium (Na) and Potassium (K) is 2-5 mEq/kg and 2-4 mEq/kg, respectively.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 349, "relevance_score": 18, "raw_id": 57}}
{"sample_id": "takeoff41_058", "track": "open_ended", "split": "holdout", "question": "What are the weight-based criteria for initiating and discontinuing the use of specialized premature infant formulas in the Neonatal Intensive Care Unit (NICU)?", "reference_answer": "These formulas are used for premature infants with a birth weight of <1800 g and are continued until the infant's current weight is >3600 g, or potentially earlier if the patient is discharged from the NICU.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 80, "relevance_score": 18, "raw_id": 58}}
{"sample_id": "takeoff41_059", "track": "open_ended", "split": "holdout", "question": "What are the specific serum sodium reference ranges for preterm neonates, term neonates, and children/adolescents, and how do they relate to adult reference values?", "reference_answer": "The serum sodium reference ranges are 130–140 mEq/L for preterm neonates, 133–146 mEq/L for term neonates, and 135–145 mEq/L for children/adolescents. Pediatric reference values are generally within 1–2 mEq/L of adult values, except for premature neonates, whose values are 3–5 mEq/L lower than adults.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 348, "relevance_score": 18, "raw_id": 59}}
{"sample_id": "takeoff41_060", "track": "open_ended", "split": "holdout", "question": "Compare the concentrations of Zinc, Manganese, and Selenium per 1 mL between Multry's and Tralement parenteral nutrition products.", "reference_answer": "Per 1 mL, Tralement contains significantly higher concentrations of these trace elements compared to Multry's: Zinc is 3000 mcg (vs 1000 mcg), Manganese is 55 mcg (vs 3 mcg), and Selenium is 60 mcg (vs 6 mcg).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 350, "relevance_score": 17, "raw_id": 60}}
{"sample_id": "takeoff41_061", "track": "open_ended", "split": "holdout", "question": "According to the guidelines for newborn and preterm neonates, when should sodium intake be restricted, and what are the recommended maintenance doses following this initial period?", "reference_answer": "Sodium and water restrictions are recommended for the first 1–2 days of life or until serum sodium drops below 133 mEq/L for term neonates and 130 mEq/L for preterm neonates. After this period, term neonates require 2–3 mEq/kg/d for maintenance, while preterm neonates recommend 2–4 mEq/kg/d for days 3–7 of life, which may increase to 4–6 mEq/kg/d for those <28 weeks gestation.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 348, "relevance_score": 17, "raw_id": 61}}
{"sample_id": "takeoff41_062", "track": "open_ended", "split": "holdout", "question": "According to ASPEN guidelines for parenteral nutrition, what are the recommended initial and daily goal protein intake ranges for preterm infants?", "reference_answer": "The recommended initial protein intake for preterm infants is 1-3 g/kg, and the daily goal protein intake is 3-4 g/kg.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 340, "relevance_score": 17, "raw_id": 62}}
{"sample_id": "takeoff41_063", "track": "open_ended", "split": "holdout", "question": "According to the provided clinical nutrition guidelines, what are the recommended daily dosage ranges for Copper, Manganese, and Selenium in neonatal trace element supplementation?", "reference_answer": "The recommended daily dosages are: Copper: 120-230 mcg/kg/day; Manganese: 1-15 mcg/kg/day; and Selenium: 7-10 mcg/kg/day.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 491, "relevance_score": 17, "raw_id": 63}}
{"sample_id": "takeoff41_064", "track": "open_ended", "split": "holdout", "question": "According to the clinical guidelines for prematurity-osteopenia, what are the recommended calcium to phosphorus ratios for enteral and parenteral nutrition supplementation?", "reference_answer": "The recommended ratio for Enteral Nutrition is 1.6:1 to 1.8:1 (mg calcium:mMol phosphorus), and for Parenteral Nutrition, it is 1.3:1 to 1.5:1 (mMol calcium:mMol phosphorus).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 502, "relevance_score": 17, "raw_id": 64}}
{"sample_id": "takeoff41_065", "track": "open_ended", "split": "holdout", "question": "What is the recommended Multry's dosing and administration frequency for a neonate weighing between 0.4 and 0.59 kg, and which trace elements require additional intake assessment according to the provided data?", "reference_answer": "For a neonate weighing 0.4-0.59 kg, the recommended dose is 0.2 ml administered every other day. Per the guidelines, additional daily intake needs should be assessed for Zinc, Copper, and Selenium to meet 'Trace Element Daily Needs'.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 350, "relevance_score": 17, "raw_id": 65}}
{"sample_id": "takeoff41_066", "track": "open_ended", "split": "holdout", "question": "What are the specific nutritional characteristics and mixing requirements for the 10 mL liquid pasteurized human milk calorie fortifier?", "reference_answer": "The 10 mL liquid fortifier provides at least 2.5 kcal/mL with no added minerals (0 mg Mg, 0 mg Fe, 0 units Vitamin D). When mixed with Prolacta HM, the osmolality is 287 mOsm/kg H2O.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 104, "relevance_score": 16, "raw_id": 66}}
{"sample_id": "takeoff41_067", "track": "open_ended", "split": "holdout", "question": "What are the clinical indications and timing requirements for initiating parenteral nutrition (PN) in infants with a birth weight of less than 1500 g?", "reference_answer": "In infants with a birth weight <1500 g, parenteral nutrition should be initiated shortly after birth. It is indicated for total or supplemental nutrition if enteral nutrition (EN) is not feasible or is insufficient to meet the infant's total nutrient needs.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 335, "relevance_score": 16, "raw_id": 67}}
{"sample_id": "takeoff41_068", "track": "open_ended", "split": "holdout", "question": "What is the calcium and phosphorus content per 100 mL for the first two toddler formulas listed, and how do they compare in terms of osmolarity?", "reference_answer": "The first two toddler formulas both contain 150 mg (6.3 mEq) of Calcium and 80 mg of Phosphorus per 100 mL. However, they differ significantly in osmolarity; the first formula has an osmolarity of 295 mOsm/kg H2O, while the second (reduced lactose) formula has a lower osmolarity of 200 mOsm/kg H2O.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 150, "relevance_score": 16, "raw_id": 68}}
{"sample_id": "takeoff41_069", "track": "open_ended", "split": "holdout", "question": "Compare the osmolarity and sodium concentration (Na) of Sodium chloride 3% against Sodium chloride 0.9% (NS) according to the chart.", "reference_answer": "Sodium chloride 3% has an osmolarity of 1027 mOsm/L and Na 513 mEq/L, while Sodium chloride 0.9% (NS) has an osmolarity of 308 mOsm/L and Na 154 mEq/L.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 354, "relevance_score": 16, "raw_id": 69}}
{"sample_id": "takeoff41_070", "track": "open_ended", "split": "holdout", "question": "What are the standard maintenance phosphorus requirements for well-nourished, nonstressed adults with normal renal function, and how do these requirements compare to patients at risk for refeeding syndrome?", "reference_answer": "Well-nourished, nonstressed adults with normal renal function typically require 10–15 mmol of phosphorus per 1000 kcal per day, or about 20–40 mmol/d. However, patients at risk for refeeding syndrome likely have higher initial requirements and may need repletion before starting nutrition support.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 317, "relevance_score": 16, "raw_id": 70}}
{"sample_id": "takeoff41_071", "track": "open_ended", "split": "holdout", "question": "What are the standard daily sodium maintenance requirements for a well-nourished adult, and how should these be adjusted for a patient at risk of refeeding syndrome and volume overload?", "reference_answer": "Well-nourished adults require 1–2 mEq/kg/d of sodium for maintenance. For patients at risk of fluid overload during refeeding, sodium should be limited to < 2 mEq/kg/d and total fluid volume should be limited to 20–25 mL/kg/d.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 320, "relevance_score": 16, "raw_id": 71}}
{"sample_id": "takeoff41_072", "track": "open_ended", "split": "holdout", "question": "Compare the sodium and potassium concentrations of the WHO Reduced Osmolarity formula to the Pedialyte formula as listed in the ORS reference table.", "reference_answer": "The WHO Reduced Osmolarity formula contains 70 mEq/L of sodium and 20 mEq/L of potassium. In contrast, Pedialyte contains a lower sodium concentration of 45 mEq/L but the same potassium concentration of 20 mEq/L.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 36, "relevance_score": 16, "raw_id": 72}}
{"sample_id": "takeoff41_073", "track": "open_ended", "split": "holdout", "question": "Compare the available forms and osmolarity (mOsm/kg H2O) of the hydrolyzed formula containing 0.6 g fiber/100 mL with the formula indicated for protein maldigestion and colic.", "reference_answer": "The hydrolyzed formula with 0.6 g fiber/100 mL is available as a 400 g powder with an osmolarity of 280 mOsm/kg H2O. In contrast, the formula for protein maldigestion/colic is available in 343g and 561g powder and multiple RTF sizes (2 oz, 237 mL, 946 mL), with an osmolarity of 370 mOsm/kg H2O for RTF and 320 mOsm/kg H2O for powder.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 138, "relevance_score": 16, "raw_id": 73}}
{"sample_id": "takeoff41_074", "track": "open_ended", "split": "holdout", "question": "According to the parenteral nutrition guidelines for infants, what is the maximum infusion rate for lipids and the daily goal intake for a preterm infant?", "reference_answer": "The daily goal for preterm infants is 3 g/kg, and the maximum infusion rate is 0.15 g/kg/hr.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 345, "relevance_score": 16, "raw_id": 74}}
{"sample_id": "takeoff41_075", "track": "open_ended", "split": "holdout", "question": "According to clinical guidelines for treating acute phosphorus depletion, what are the primary clinical considerations and adverse effects when opting for intravenous (IV) phosphate repletion over oral repletion?", "reference_answer": "IV repletion corrects hypophosphatemia more rapidly than oral routes but carries risks of thrombophlebitis, hypocalcemia, arrhythmias, ectopic calcification, and acute kidney injury (AKI). Clinically, IV replacement is generally reserved for severe hypophosphatemia (serum phosphorus < 1 mg/dL) or symptomatic moderate cases, and infusion rates should be limited to no more than 7 mmol phosphate per hour to minimize the risk of calcium/phosphate precipitation.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 181, "relevance_score": 16, "raw_id": 75}}
{"sample_id": "takeoff41_076", "track": "open_ended", "split": "holdout", "question": "What is the targeted Glucose Infusion Rate (GIR) for adult patients requiring formula feeds or cornstarch dosing for Glycogen Storage Disease Type I?", "reference_answer": "The targeted Glucose Infusion Rate (GIR) for adults is 3-4 mg/kg/min.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 471, "relevance_score": 16, "raw_id": 76}}
{"sample_id": "takeoff41_077", "track": "open_ended", "split": "holdout", "question": "In patients older than one year, what is the clinical justification for the PRN addition of Cysteine to parenteral nutrition, and what is its standard dosing concentration relative to protein intake?", "reference_answer": "Cysteine is added PRN to improve calcium/phosphorus solubility in the PN formulation; the standard daily dosing is 40 mg per gram of protein.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 353, "relevance_score": 16, "raw_id": 77}}
{"sample_id": "takeoff41_078", "track": "open_ended", "split": "holdout", "question": "According to the premature infant formula table, what is the caloric density (kcal per 100 mL) of Enfamil® Premature 24 HP Cal compared to preterm human milk?", "reference_answer": "Enfamil® Premature 24 HP Cal provides 81.2 kcal per 100 mL, whereas preterm human milk provides 67 kcal per 100 mL.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 91, "relevance_score": 16, "raw_id": 78}}
{"sample_id": "takeoff41_079", "track": "open_ended", "split": "holdout", "question": "According to evidence-based management of distal small bowel losses, what are the recommended fluid replacement ratios and electrolyte concentrations for maintenance?", "reference_answer": "In general, it is appropriate to administer 0.5–1 mL of fluid replacement solution for every 1 mL of GI fluid lost. Replacement solutions should contain sodium at concentrations of 130–154 mEq/L (such as 0.9% NaCl or lactated Ringer's) to mimic normal small bowel fluid content, often with the addition of 10–20 mEq/L of potassium chloride to prevent concomitant hypokalemia.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 289, "relevance_score": 16, "raw_id": 79}}
{"sample_id": "takeoff41_080", "track": "open_ended", "split": "holdout", "question": "According to clinical guidelines for Glycogen Storage Disease Type I, what is the recommended Glucose Infusion Rate (GIR) for a child aged 1-3 years?", "reference_answer": "The recommended Glucose Infusion Rate (GIR) for children aged 1-3 years is 7 mg/kg/min.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 471, "relevance_score": 16, "raw_id": 80}}
{"sample_id": "takeoff41_081", "track": "open_ended", "split": "holdout", "question": "According to neonatal clinical standards for birth weight classifications, how are Low Birth Weight (LBW), Very Low Birth Weight (VLBW), and Extremely Low Birth Weight (ELBW) defined?", "reference_answer": "Low Birth Weight (LBW) is defined as <2500 g at birth, Very Low Birth Weight (VLBW) is <1500 g at birth, and Extremely Low Birth Weight (ELBW) is <1000 g at birth.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 489, "relevance_score": 16, "raw_id": 81}}
{"sample_id": "takeoff41_082", "track": "open_ended", "split": "holdout", "question": "Under what specific conditions can the maximum potassium infusion rate of 20 mEq/h be utilized, and what monitoring is required?", "reference_answer": "A maximum infusion rate of 20 mEq/h may be used if the patient has central venous access; in these instances, continuous cardiac monitoring is required.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 100, "relevance_score": 15, "raw_id": 82}}
{"sample_id": "takeoff41_083", "track": "open_ended", "split": "holdout", "question": "According to evidence-based management for hypervolemia, what are the daily recommended limits for sodium and water intake to decrease extracellular fluid (ECF) volume excess?", "reference_answer": "The daily limits are < 45–90 mEq/d (or 2–4 g/d) for sodium and 1–1.5 L/d for water, ensuring all sources such as IV fluids, parenteral nutrition, and oral intake are included.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 42, "relevance_score": 15, "raw_id": 83}}
{"sample_id": "takeoff41_084", "track": "open_ended", "split": "holdout", "question": "Based on the classification of metabolic acidosis, name three specific causes categorized as Non-Anion Gap and identify the specific dosing threshold for propofol that leads to Anion Gap acidosis.", "reference_answer": "Non-Anion Gap causes include Gastrointestinal loss of HCO3- (such as high-output ostomy > 1 L/d), overuse of chloride salts in parenteral nutrition, and renal tubular acidosis; propofol can lead to Anion Gap acidosis at doses > 80 mcg/kg/min for > 48 h.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 236, "relevance_score": 15, "raw_id": 84}}
{"sample_id": "takeoff41_085", "track": "open_ended", "split": "holdout", "question": "Based on the provided nutritional chart, identify the protein sources and the percentage of calories derived from protein for the first formula compared to the others listed.", "reference_answer": "The first formula utilizes organic pea protein as its protein source, accounting for 18% of its total calories (6.2g). In contrast, the other three formulas utilize a combination of soy protein isolate, sodium caseinate, and calcium caseinate, providing between 16% (4g) and 18% (6.8g) of their caloric content.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 258, "relevance_score": 15, "raw_id": 85}}
{"sample_id": "takeoff41_086", "track": "open_ended", "split": "holdout", "question": "What are the estimated oral/enteral protein requirements for a preterm infant with a current weight of 1500–2000 grams?", "reference_answer": "The estimated oral/enteral protein requirements for a preterm infant weighing 1500–2000 g are 3–4 g protein/kg/day, though this should be adjusted based on growth trends and clinical status.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 490, "relevance_score": 15, "raw_id": 86}}
{"sample_id": "takeoff41_087", "track": "open_ended", "split": "holdout", "question": "How do the daily goal lipid intake and the minimum requirements for essential fatty acids differ between preterm infants and children aged 0-2 years?", "reference_answer": "Both groups share a daily goal of 3 g/kg; however, the minimum for essential fatty acid needs is specified as 2.2 g/kg for preterm infants, whereas it is defined as 30% of total calories for the 0-2 years old age group.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 346, "relevance_score": 15, "raw_id": 87}}
{"sample_id": "takeoff41_088", "track": "open_ended", "split": "holdout", "question": "Which formula contains dietary fiber, and what is the recorded osmolarity for that formula at a concentration of 33 kcal/oz?", "reference_answer": "The formula indicated for PKU contains 11.2 g of fiber, whereas the other formula contains 0 g. The osmolarity for the PKU formula at 33 kcal/oz is 1340 mOsm/kg H2O.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 212, "relevance_score": 15, "raw_id": 88}}
{"sample_id": "takeoff41_089", "track": "open_ended", "split": "holdout", "question": "Compare the osmolality and indications for the 50 mL and 118 mL pasteurized human milk liquid forms provided in the text.", "reference_answer": "The 50 mL liquid form has an osmolality of 367 mOsm/kg H2O when mixed with Prolacta HM and must be mixed with 50 mL of human milk to achieve 30 kcal/oz. The 118 mL liquid form has an osmolality of 290 mOsm/kg H2O and is indicated for use when mother's milk is unavailable, providing at least 67 kcal/100mL.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 104, "relevance_score": 15, "raw_id": 89}}
{"sample_id": "takeoff41_090", "track": "open_ended", "split": "holdout", "question": "Compare the protein sources and total protein content (per specified unit) between Similac Special Care 24 and Similac Special Care 30 as listed in the premature infant formula chart.", "reference_answer": "Similac Special Care 24 contains 2.4 g (12%) of protein sourced from nonfat milk and whey protein concentrate. Similac Special Care 30 contains 101.4 kcal total with a protein focus, though the chart lists the per-packet fortifier protein separately as 0.275 g (32%) from milk protein isolate and whey protein isolate hydrolysate.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 96, "relevance_score": 15, "raw_id": 90}}
{"sample_id": "takeoff41_091", "track": "open_ended", "split": "holdout", "question": "What is the recommended dosing and physiological rationale for adding Carnitine to parenteral nutrition formulations in pediatric patients aged 0-1 years?", "reference_answer": "The standard daily dosing is 10-20 mg/kg. It is considered a conditionally essential amino acid for this age group, required for the transport of long chain fatty acids into the mitochondria for oxidation and energy production.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 353, "relevance_score": 15, "raw_id": 91}}
{"sample_id": "takeoff41_092", "track": "open_ended", "split": "holdout", "question": "Compare the Vitamin D and Magnesium content per unit between the human milk column and the highest-valued premature formula column provided in the table.", "reference_answer": "Human milk contains 2 units of Vitamin D and 3.1 mg of Magnesium, whereas the highest-valued premature formula contains 240 units of Vitamin D and 7.3 mg of Magnesium.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 93, "relevance_score": 14, "raw_id": 92}}
{"sample_id": "takeoff41_093", "track": "open_ended", "split": "holdout", "question": "For a preterm infant weighing between 500 and 2000 grams, what are the daily estimated caloric needs to support growth?", "reference_answer": "For a preterm infant weighing 500–2000 g, the estimated enteral caloric needs are 110–130 kcal/kg/day.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 490, "relevance_score": 14, "raw_id": 93}}
{"sample_id": "takeoff41_094", "track": "open_ended", "split": "holdout", "question": "What are the specific dosage and administration timing guidelines for thiamine supplementation to prevent refeeding syndrome?", "reference_answer": "Thiamine should be administered at 2 mg/kg/day (maximum 100–200 mg/day) and must be started before any nutrition intake, including intravenous fluids or oral intake. Intravenous administration is preferred, although enteral/oral routes are acceptable.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 369, "relevance_score": 14, "raw_id": 94}}
{"sample_id": "takeoff41_095", "track": "open_ended", "split": "holdout", "question": "Based on the provided formulary data, how do Jevity 1.2 Cal and Kate Farms Standard 1.0 compare in terms of caloric density (Kcal) and specific fiber or carbohydrate sources per 100 mL?", "reference_answer": "Jevity 1.2 Cal provides 120 Kcal per 100 mL and utilizes corn maltodextrin, corn syrup solids, short chain fructooligosaccharides, soy fiber, and oat fiber as its CHO/fiber source. In contrast, Kate Farms Standard 1.0 provides 100 Kcal per 100 mL and utilizes corn maltodextrin, corn syrup solids, brown rice solids, and organic soluble inulin from agave.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 255, "relevance_score": 14, "raw_id": 95}}
{"sample_id": "takeoff41_096", "track": "open_ended", "split": "holdout", "question": "Compare the sodium, potassium, and calcium content (in mg) of Fortini™ Infant Nutricia® with that of Gerber® Good Start® Gentle.", "reference_answer": "Fortini™ Infant Nutricia® contains higher concentrations of electrolytes and minerals than Gerber® Good Start® Gentle, providing 37 mg of sodium, 95 mg of potassium, and 100 mg of calcium, while Gerber® Good Start® Gentle provides 18 mg of sodium, 73 mg of potassium, and 45 mg of calcium.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 110, "relevance_score": 14, "raw_id": 96}}
{"sample_id": "takeoff41_097", "track": "open_ended", "split": "holdout", "question": "Under what clinical circumstances might a preterm infant require up to 6 mg/kg/day of iron, and what are the contraindications for prolonged high-dose intake?", "reference_answer": "Infants receiving erythropoietin or those with significant blood losses may require up to 6 mg/kg/day; however, prolonged intake exceeding 3 mg/kg/day or use alongside frequent transfusions should be avoided due to potential adverse effects.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 497, "relevance_score": 14, "raw_id": 97}}
{"sample_id": "takeoff41_098", "track": "open_ended", "split": "holdout", "question": "According to the Tralement dosing table, which weight categories require additional supplementation of Zinc, Copper, and Selenium to meet daily needs and which category requires none?", "reference_answer": "Weight categories 10-19 kg, 20-29 kg, 30-39 kg, and 40-49 kg require additional Zinc, Copper, and Selenium; whereas the category for patients weighing ≥50 kg requires no additional trace elements.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 352, "relevance_score": 14, "raw_id": 98}}
{"sample_id": "takeoff41_099", "track": "open_ended", "split": "holdout", "question": "What is the primary diagnostic criterion for Refeeding Syndrome, and how is the electrolyte management prioritized during the initial 24-48 hours?", "reference_answer": "Refeeding Syndrome is characterized by a significant drop in phosphorus, potassium, and/or magnesium levels upon reintroduction of calories. Management prioritizes thiamine supplementation (200-300mg/day) and slow caloric titration, starting at 10-20 kcal/kg/day, while monitoring and replacing electrolytes frequently.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 30, "relevance_score": 22, "raw_id": 99}}
{"sample_id": "takeoff41_100", "track": "open_ended", "split": "holdout", "question": "In the management of Refeeding Syndrome, what are the specific clinical thresholds for serum phosphorus and magnesium that necessitate a 50% reduction in caloric intake advancement?", "reference_answer": "Clinical practice guidelines suggest that if serum phosphorus, magnesium, or potassium levels drop below the lower limit of normal (typically phosphorus <0.85 mmol/L or magnesium <0.70 mmol/L) during the first 72 hours of nutritional repletion, caloric intake should be restricted to approximately 10-15 kcal/kg and electrolyte replacement should be prioritized.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "calculation", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 61, "relevance_score": 22, "raw_id": 100}}
{"sample_id": "takeoff41_101", "track": "open_ended", "split": "holdout", "question": "Under what specific clinical conditions and for what duration is Peripheral Parenteral Nutrition (PPN) generally indicated, and what are its primary physiological limitations?", "reference_answer": "PPN is generally indicated as a short-term nutrition support intervention (typically 3–7 days) until a patient can transition to central parenteral nutrition (CPN) or enteral nutrition (EN). Its primary limitations include a maximum dextrose concentration of 12.5% and a total solution osmolarity typically capped between 600–900 mOsm/L, which frequently prevents the solution from meeting 100% of the patient's estimated calorie and protein requirements.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 152, "relevance_score": 21, "raw_id": 101}}
{"sample_id": "takeoff41_102", "track": "open_ended", "split": "holdout", "question": "Which factors enhance the solubility of calcium and phosphorus in parenteral nutrition solutions, and what safety measures are recommended to prevent potential fatal pulmonary emboli from precipitates?", "reference_answer": "Solubility is enhanced by an acidic solution pH (achieved via pediatric amino acids, cysteine addition, and higher amino acid/dextrose concentrations), decreased solution temperature, and the use of calcium gluconate rather than calcium chloride. Safety recommendations include calculating mineral amounts, performing solubility checks during compounding, and filtering PN solutions with a 1.2-micron filter during administration.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1151, "relevance_score": 20, "raw_id": 102}}
{"sample_id": "takeoff41_103", "track": "open_ended", "split": "holdout", "question": "What is the specific FDA-approved indication for fish oil-based ILE (FO-ILE), such as Omegaven, in the pediatric population?", "reference_answer": "FO-ILE is indicated as a source of calories and fatty acids in pediatric patients with parenteral nutrition-associated cholestasis (PNAC) or established Intestinal Failure-Associated Liver Disease (IFALD).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 157, "relevance_score": 20, "raw_id": 103}}
{"sample_id": "takeoff41_104", "track": "open_ended", "split": "holdout", "question": "What are the primary clinical indications for the preoperative or intraoperative placement of a central venous access device (such as a PICC line) in neonates with esophageal atresia?", "reference_answer": "Central venous access is placed because the infant will rely on parenteral nutrition (PN) for at least 7 days postoperatively. While peripheral PN may be used initially, central PN is required for escalation, particularly in preterm or low birth weight infants undergoing stabilization.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 959, "relevance_score": 20, "raw_id": 104}}
{"sample_id": "takeoff41_105", "track": "open_ended", "split": "holdout", "question": "In the context of parenteral nutrition (PN), how should trace element supplementation be modified for neonatal patients presenting with cholestasis or renal dysfunction?", "reference_answer": "In patients with cholestasis, copper and manganese should be reduced because they are excreted via the biliary system; in cases of renal dysfunction, parenteral intake of selenium and chromium should be reduced or held.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 200, "relevance_score": 20, "raw_id": 105}}
{"sample_id": "takeoff41_106", "track": "open_ended", "split": "holdout", "question": "What are the recommended management options for providing parenteral nutrition to a patient with a documented egg allergy, given that egg proteins are found in intravenous fat emulsions (IVFE)?", "reference_answer": "Options include: (1) consulting with an allergist to perform a skin prick test (SPIT); (2) utilizing fat-free parenteral nutrition; or (3) using alternative lipid emulsions such as fish oil-based (e.g., Omegaven) or combination lipids (e.g., Smoflipid or Clinolipid), though these still contain some egg phospholipid.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 560, "relevance_score": 20, "raw_id": 106}}
{"sample_id": "takeoff41_107", "track": "open_ended", "split": "holdout", "question": "What nutritional interventions or modifications have been investigated to prevent or treat liver dysfunction in patients requiring long-term total parenteral nutrition (TPN)?", "reference_answer": "Investigated interventions include the use of cyclic TPN to prevent deterioration of liver function, the addition of choline or L-carnitine to the parenteral formula, the use of ursodiol for cholestasis, and the transition to alternative lipid emulsions such as olive oil-based or fish oil-based products.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 361, "relevance_score": 19, "raw_id": 107}}
{"sample_id": "takeoff41_108", "track": "open_ended", "split": "holdout", "question": "In patients requiring long-term parenteral nutrition (PN), what are the primary clinical indicators for monitoring PNALD (Parenteral Nutrition-Associated Liver Disease)?", "reference_answer": "Clinical monitoring for PNALD involves regular assessment of serum conjugated (direct) bilirubin levels, which is the primary marker. Elevated alkaline phosphatase and transaminases are also monitored alongside imaging for steatosis or cholestasis. Management often involves cycling PN and optimizing lipid emulsion ratios, such as incorporating omega-3 fatty acids.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 113, "relevance_score": 19, "raw_id": 108}}
{"sample_id": "takeoff41_109", "track": "open_ended", "split": "holdout", "question": "Based on the CDC and clinical guidelines regarding refeeding syndrome, what specific micronutrient deficiency has been linked to cases of lactic acidosis in patients receiving total parenteral nutrition (TPN) during multivitamin shortages?", "reference_answer": "Thiamine deficiency has been clinically linked to the development of lactic acidosis in patients receiving parenteral nutrition, particularly during periods of multivitamin shortages.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 329, "relevance_score": 19, "raw_id": 109}}
{"sample_id": "takeoff41_110", "track": "open_ended", "split": "holdout", "question": "Based on clinical nutrition standards for parenteral nutrition (PN), what are the specific considerations regarding osmolarity for central versus peripheral administration?", "reference_answer": "The osmolarity of parenteral nutrition (PN) determines the administration route; peripheral parenteral nutrition (PPN) is generally limited to an osmolarity of less than 900 mOsm/L to prevent thrombophlebitis, whereas central venous access is required for formulations with higher osmolarity (typically cited in the range of 600-900 mOsm/L for peripheral limits).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 496, "relevance_score": 19, "raw_id": 110}}
{"sample_id": "takeoff41_111", "track": "open_ended", "split": "holdout", "question": "Identify three specific modifications to Parenteral Nutrition (PN) formulations or administration strategies mentioned to treat or avert IFALD, and describe the mechanism of fish oil-based lipid emulsions in addressing cholestasis.", "reference_answer": "Modifications include 'cycling' PN for <24 hours, limiting dextrose to decrease steatosis, and reducing aluminum and manganese content. Fish oil-based lipid emulsions treat cholestasis by lacking phytosterols (which inhibit the farnesoid X receptor) and minimizing pro-inflammatory omega-6 fatty acids.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 817, "relevance_score": 19, "raw_id": 111}}
{"sample_id": "takeoff41_112", "track": "open_ended", "split": "holdout", "question": "What is the clinical definition and significance of Parenteral Nutrition-Associated Liver Disease (PNALD)?", "reference_answer": "PNALD is a spectrum of hepatobiliary disorders, including steatosis, cholestasis, and gallbladder sludge, primarily caused by long-term PN usage. It is significant because it can progress to cirrhosis and liver failure, often requiring the use of specialized lipid emulsions or a transition to enteral nutrition.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 2, "relevance_score": 19, "raw_id": 112}}
{"sample_id": "takeoff41_113", "track": "open_ended", "split": "holdout", "question": "How does the use of central venous access impact the risk of thrombophlebitis during the administration of high-osmolarity parenteral nutrition solutions?", "reference_answer": "Central venous access reduces the risk of thrombophlebitis by delivering the hyperosmolar TPN solution directly into a high-volume, high-flow vessel where it is quickly diluted, thereby minimizing the chemical irritation to the vein wall.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 281, "relevance_score": 18, "raw_id": 113}}
{"sample_id": "takeoff41_114", "track": "open_ended", "split": "holdout", "question": "What are the specific energy and fluid management recommendations for individuals experiencing a catabolic crisis requiring aggressive nutrition support, particularly regarding glucose infusion and cerebral edema risk?", "reference_answer": "Individuals may require 1.5 to more than 2 times the estimated energy expenditure for age. Management includes starting with 10% dextrose (D10) at an age-appropriate glucose infusion rate (GIR), potentially using higher concentrations via central access. Crucially, excess fluid administration and hypotonic solutions must be avoided due to the high risk for cerebral edema, ensuring normal serum osmolarity.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 335, "relevance_score": 18, "raw_id": 114}}
{"sample_id": "takeoff41_115", "track": "open_ended", "split": "holdout", "question": "According to the literature on pediatric intestinal failure (IF), what specific four-oil component intravenous fat emulsion (IVFE) was compared to soybean oil-based emulsions (Intralipid) in terms of its impact on the evolution of intestinal failure-associated liver disease (IFALD)?", "reference_answer": "Smoflipid, which contains soybean oil, medium-chain triglycerides, olive oil, and fish oil, was studied in both randomized and observational settings (Goulet et al., 2010; Belza et al., 2020) to evaluate its efficacy and safety compared to standard soybean oil-based emulsions like Intralipid in pediatric patients.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 833, "relevance_score": 18, "raw_id": 115}}
{"sample_id": "takeoff41_116", "track": "open_ended", "split": "holdout", "question": "Under what specific clinical conditions is Parenteral Nutrition (PN) indicated for patients with Chronic Kidney Disease (CKD) according to the guidelines, and why is central venous access required for stage 5 patients?", "reference_answer": "PN may be necessary for patients with mild to severe intolerance of oral or enteral supplements due to gastrointestinal (GI) dysfunction to ensure adequate nutrition for catch-up growth. In CKD stage 5, central venous access is required to accommodate concentrated, high-osmolarity solutions necessitated by the patient's fluid restriction.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 699, "relevance_score": 17, "raw_id": 116}}
{"sample_id": "takeoff41_117", "track": "open_ended", "split": "holdout", "question": "What are the physiological consequences of exceeding the maximum glucose oxidation rate in pediatric patients receiving parenteral nutrition, particularly regarding very low birth weight preterm neonates and long-term PN patients?", "reference_answer": "Exceeding the glucose oxidation or infusion rate results in fat production, which may be desired in the short term for very low birth weight preterm neonates. However, in long-term PN patients, excess glucose is associated with hepatic steatosis and increases the risk for Intestinal Failure Associated Liver Disease (IFALD).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1146, "relevance_score": 17, "raw_id": 117}}
{"sample_id": "takeoff41_118", "track": "open_ended", "split": "holdout", "question": "What are the specific laboratory and clinical monitoring requirements for a patient transitioning from parenteral nutrition to enteral nutrition to prevent refeeding syndrome?", "reference_answer": "Monitoring involves tracking phosphorus, potassium, and magnesium levels (often daily for the first 3-5 days), managing fluid balance to avoid sodium-induced edema, and gradually increasing caloric intake starting at 25-50% of goals while thiamine is supplemented.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 80, "relevance_score": 17, "raw_id": 118}}
{"sample_id": "takeoff41_119", "track": "open_ended", "split": "holdout", "question": "In the context of Parenteral Nutrition (PN), what is the clinical definition of Refeeding Syndrome and what are the hallmark electrolyte imbalances associated with its onset?", "reference_answer": "Refeeding Syndrome is a potentially fatal shift in fluids and electrolytes that occurs in malnourished patients receiving artificial refeeding. The hallmark electrolyte imbalances are hypophosphatemia, hypokalemia, and hypomagnesemia, often accompanied by vitamin B1 (thiamine) deficiency and fluid retention.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 23, "relevance_score": 17, "raw_id": 119}}
{"sample_id": "takeoff41_120", "track": "open_ended", "split": "holdout", "question": "In patients with intestinal failure-associated liver disease (IFALD) on long-term parenteral nutrition, what are the hematological and skeletal risks of copper deficiency, and how should copper supplementation be managed in cases of cholestasis?", "reference_answer": "Copper deficiency can result in anemia (specifically microcytic hypochromic anemia unresponsive to iron), thrombocytopenia, neutropenia, and osteopenia. Because copper undergoes biliary excretion, the dosage should be reduced in patients with cholestasis, though not eliminated entirely without periodic monitoring to avoid hypocupremia.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 202, "relevance_score": 17, "raw_id": 120}}
{"sample_id": "takeoff41_121", "track": "open_ended", "split": "holdout", "question": "In a patient receiving parenteral nutrition (PN) who develops cholestasis characterized by conjugated hyperbilirubinemia, what is the most appropriate modification to the lipid component of the PN formulation according to clinical evidence?", "reference_answer": "The most appropriate modification is to switch to a fish oil-based lipid emulsion, as PNALD/cholestasis can be driven by pro-inflammatory omega-6 fatty acids found in traditional emulsions, whereas fish oil-based emulsions are associated with the reversal or mitigation of cholestasis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 7, "relevance_score": 17, "raw_id": 121}}
{"sample_id": "takeoff41_122", "track": "open_ended", "split": "holdout", "question": "In a stable patient receiving Parenteral Nutrition (PN) who develops acute hyperglycemia, what are the recommended initial interventions before starting insulin therapy?", "reference_answer": "The easiest and safest initial interventions are to decrease the Glucose Infusion Rate (GIR) or extend the PN cycle while performing a clinical work-up to determine the underlying etiology, such as infection.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1223, "relevance_score": 16, "raw_id": 122}}
{"sample_id": "takeoff41_123", "track": "open_ended", "split": "holdout", "question": "In the management of Refeeding Syndrome, what is the primary electrolyte abnormality that must be monitored, and what are the specific clinical recommendations for initial caloric intake?", "reference_answer": "The primary electrolyte abnormality is hypophosphatemia, caused by insulin-induced intracellular shifts. Clinical recommendations suggest limiting initial caloric intake to 10-20 kcal/kg per day (or 25-50% of estimated energy requirements) while aggressively monitoring and replacing phosphorus, potassium, and magnesium.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 135, "relevance_score": 16, "raw_id": 123}}
{"sample_id": "takeoff41_124", "track": "open_ended", "split": "holdout", "question": "What are the common metabolic complications associated with parenteral nutrition, and how should they be monitored to maintain patient safety?", "reference_answer": "Common metabolic complications include hyperglycemia, hypertriglyceridemia, electrolyte imbalances (such as hypokalemia or hypophosphatemia), and refeeding syndrome. Monitoring requires frequent blood glucose checks, serum electrolyte panels, and lipid profile assessments according to clinical protocols.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 2, "relevance_score": 16, "raw_id": 124}}
{"sample_id": "takeoff41_125", "track": "open_ended", "split": "holdout", "question": "Explain the pathogenesis of Refeeding Syndrome in the context of initiating parenteral nutrition in a malnourished patient.", "reference_answer": "Refeeding Syndrome occurs when the introduction of concentrated glucose triggers an insulin surge, leading to a rapid intracellular shift of electrolytes. This results in severe serum deficiencies of phosphorus, magnesium, and potassium, which can lead to cardiac arrhythmias, respiratory failure, and death.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 2, "relevance_score": 16, "raw_id": 125}}
{"sample_id": "takeoff41_126", "track": "open_ended", "split": "holdout", "question": "What clinical monitoring parameters are essential for preventing Refeeding Syndrome in patients transitioning from severe malnutrition to full-strength Parenteral Nutrition?", "reference_answer": "Essential monitoring includes baseline and daily assessments of serum electrolytes, specifically phosphorus, potassium, and magnesium, along with blood glucose levels and fluid balance to prevent cardiac and respiratory complications during the reintroduction of calories.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 228, "relevance_score": 16, "raw_id": 126}}
{"sample_id": "takeoff41_127", "track": "open_ended", "split": "holdout", "question": "In the context of parenteral nutrition for neonatal populations, why is the availability of L-cysteine critical according to ASPEN shortage considerations?", "reference_answer": "L-cysteine is critical because it is an essential amino acid for neonates and serves as a buffering agent that lowers the pH of the parenteral nutrition solution, which increases the solubility of calcium and phosphates, thereby allowing for higher concentrations of these minerals required for bone mineralization in infants.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 249, "relevance_score": 16, "raw_id": 127}}
{"sample_id": "takeoff41_128", "track": "open_ended", "split": "holdout", "question": "Describe the physiological criteria for diagnosing refeeding syndrome and the electrolyte management protocol required to mitigate risks during nutritional rehabilitation.", "reference_answer": "Refeeding syndrome is characterized by severe electrolyte shifts, primarily hypophosphatemia, hypokalemia, and hypomagnesemia, resulting from insulin release during carbohydrate reintroduction. Clinical management involves starting calories at 10-15 kcal/kg, restricting fluid, and aggressively supplementing phosphorus, magnesium, and potassium while monitoring serum levels every 6-12 hours during the initial phase.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 72, "relevance_score": 16, "raw_id": 128}}
{"sample_id": "takeoff41_129", "track": "open_ended", "split": "holdout", "question": "For a stable patient on cyclic parenteral nutrition (PN) who develops new-onset hyperglycemia, which management strategy is considered an unacceptable clinical response?", "reference_answer": "Starting subcutaneous long-acting insulin is NOT an acceptable response. Appropriate actions include decreasing the Glucose Infusion Rate (GIR), increasing the duration of the PN cycle time, or conducting a work-up for infection.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1214, "relevance_score": 16, "raw_id": 129}}
{"sample_id": "takeoff41_130", "track": "open_ended", "split": "holdout", "question": "What specific threshold for intravenous lipid emulsion (ILE) intake has been strongly associated with chronic cholestasis and severe intestinal failure-associated liver disease (IFALD) in patients receiving long-term parenteral nutrition?", "reference_answer": "Multivariate analysis indicates that an ILE intake of greater than 1 g/kg/d is strongly associated with chronic cholestasis and severe IFALD in patients receiving long-term PN.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 349, "relevance_score": 16, "raw_id": 130}}
{"sample_id": "takeoff41_131", "track": "open_ended", "split": "holdout", "question": "Under what specific clinical circumstances should parenteral nutrition (PN) be promptly initiated or prioritized over enteral nutrition in neonatal and pediatric populations?", "reference_answer": "PN should be promptly initiated in very low birth weight infants (<1500 g). It should also be used when the gastrointestinal tract is non-functional or has inadequate absorption, for neonates in critical care when EN does not meet energy needs for growth, and for malnourished patients unable to tolerate oral/enteral intake during perioperative stages.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1185, "relevance_score": 15, "raw_id": 131}}
{"sample_id": "takeoff41_132", "track": "open_ended", "split": "holdout", "question": "What are the clinical benefits and potential risks associated with adding cysteine to neonatal parenteral nutrition at the time of compounding?", "reference_answer": "Cysteine improves nitrogen balance and normalizes the plasma amino acid profile in neonates. It also decreases the pH of the parenteral nutrition solution, which improves calcium and phosphorus solubility. However, because it is a chloride salt, it may predispose the neonate to metabolic acidosis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 194, "relevance_score": 15, "raw_id": 132}}
{"sample_id": "takeoff41_133", "track": "open_ended", "split": "holdout", "question": "According to the studies by Laborie et al. and Lavoie et al., what specific components of a multivitamin preparation are identified as major contributors to the paradoxically high in vitro generation of peroxides in total parenteral nutrition (TPN) solutions?", "reference_answer": "Ascorbic acid and riboflavin are identified as key components that contribute to the photoinduced generation of peroxides when multivitamin preparations are added to parenteral nutrition solutions.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1181, "relevance_score": 15, "raw_id": 133}}
{"sample_id": "takeoff41_134", "track": "open_ended", "split": "holdout", "question": "Based on historical clinical data, what is the reported incidence of Intestinal Failure-Associated Liver Disease (IFALD) in infants receiving parenteral nutrition (PN) for two months, and what percentage of preterm infants develop end-stage liver disease after three months of PN?", "reference_answer": "The incidence of IFALD is as high as 50% in infants receiving PN for 2 months, and end-stage liver disease develops in 90% of preterm infants on PN for more than 3 months.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 817, "relevance_score": 15, "raw_id": 134}}
{"sample_id": "takeoff41_135", "track": "open_ended", "split": "holdout", "question": "Define the various categories of complications associated with Parenteral Nutrition (PN) as identified in the source text.", "reference_answer": "Complications of PN are categorized into hepatobiliary (including PNAC and PNALD), macronutrient-related, micronutrient-related, metabolic bone disease, and refeeding syndrome.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 497, "relevance_score": 15, "raw_id": 135}}
{"sample_id": "takeoff41_136", "track": "open_ended", "split": "holdout", "question": "In what order should electrolytes be listed on a standardized PN order template according to Table 5-1?", "reference_answer": "Electrolytes should be listed in the following sequence: Sodium phosphate, Sodium chloride, Sodium acetate, Potassium phosphate, Potassium chloride, Magnesium sulfate or magnesium chloride, and finally Calcium gluconate.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 251, "relevance_score": 15, "raw_id": 136}}
{"sample_id": "takeoff41_137", "track": "open_ended", "split": "holdout", "question": "In a patient diagnosed with severe malnutrition, what is the recommended strategy for initiating Parenteral Nutrition (PN) to minimize the risk of refeeding syndrome?", "reference_answer": "The appropriate strategy is to start Parenteral Nutrition (PN) at approximately 50% of the patient's estimated energy requirements and gradually advance to full goals over a period of 3 to 5 days. Immediate initiation of full caloric needs is contraindicated due to the risk of metabolic complications.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 262, "relevance_score": 15, "raw_id": 137}}
{"sample_id": "takeoff41_138", "track": "open_ended", "split": "holdout", "question": "According to the Michigan Appropriateness Guide for Intravenous Catheters (MAGIC), what are the primary considerations for choosing between a peripherally inserted central catheter (PICC) and other central venous access devices for parenteral nutrition?", "reference_answer": "Selection depends on the expected duration of therapy, the clinical setting (acute vs. home care), and the patient's individual risk factors for complications such as venous thromboembolism (VTE) and catheter-related bloodstream infections (CRBSI).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 222, "relevance_score": 15, "raw_id": 138}}
{"sample_id": "takeoff41_139", "track": "open_ended", "split": "holdout", "question": "Which micronutrients are most commonly found to be deficient in patients adhering to medical ketogenic diets, and what are the general supplementation recommendations for children?", "reference_answer": "The nutrients most commonly deficient are Vitamin B₁, Vitamin D, Magnesium, Phosphorus, Copper, Zinc, Selenium, and Carnitine. Most children will require a multivitamin and a vitamin D/calcium supplement. Additionally, salt or potassium supplementation may be necessary based on laboratory results and calculated intake.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 411, "relevance_score": 15, "raw_id": 139}}
{"sample_id": "takeoff41_140", "track": "open_ended", "split": "holdout", "question": "What clinical criteria and biochemical markers are used to identify and diagnose Refeeding Syndrome in malnourished patients during the reintroduction of calories?", "reference_answer": "Refeeding Syndrome is characterized by acute intracellular shifts of electrolytes triggered by insulin release during carbohydrate reintroduction. Diagnostic criteria include a critical drop in serum phosphorus (hypophosphatemia), potassium (hypokalemia), and magnesium (hypomagnesemia), often accompanied by thiamine deficiency and fluid retention.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 117, "relevance_score": 15, "raw_id": 140}}
{"sample_id": "takeoff41_141", "track": "open_ended", "split": "holdout", "question": "How do specialized nutrition supports, specifically Enteral and Parenteral Nutrition, differ in their administration and monitoring requirements for pediatric populations?", "reference_answer": "Enteral nutrition (EN) is delivered via the gastrointestinal tract and generally requires monitoring for gut tolerance and tube placement, whereas Parenteral Nutrition (PN) is delivered intravenously and requires stringent monitoring of biochemical parameters, fluid/electrolyte balance, and central venous access complications.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 987, "relevance_score": 15, "raw_id": 141}}
{"sample_id": "takeoff41_142", "track": "open_ended", "split": "holdout", "question": "In the management of parenteral nutrition for SBS patients, why are blended lipid injectable emulsions (ILEs) preferred over traditional soy oil-based ILEs, and how should iron be administered?", "reference_answer": "Blended ILEs are preferred because they have a lower risk of cholestasis and intestinal failure-associated liver disease (IFALD); iron must be given orally, enterally, or via intravenous infusion because it is incompatible with 3-in-1 PN preparations.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 422, "relevance_score": 15, "raw_id": 142}}
{"sample_id": "takeoff41_143", "track": "open_ended", "split": "holdout", "question": "In the context of Refeeding Syndrome, which electrolyte abnormalities are most characteristic, and what is the recommended caloric initiation rate to prevent clinical decompensation?", "reference_answer": "Refeeding Syndrome is characterized by hypophosphatemia, hypokalemia, and hypomagnesemia, along with vitamin deficiencies such as thiamine. To prevent decompensation, calories should be initiated at 10–20 kcal/kg per day or 25% of estimated energy needs, and titrated slowly over 3–5 days while monitoring electrolytes.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 32, "relevance_score": 15, "raw_id": 143}}
{"sample_id": "takeoff41_144", "track": "open_ended", "split": "holdout", "question": "According to the ASPEN position paper, what are the primary clinical reasons for implementing photoprotection for parenteral nutrition (PN) in neonates and premature infants?", "reference_answer": "The primary reasons include preventing the degradation of light-sensitive vitamins and ingredients and reducing the formation of oxidant chemical species, such as peroxides (hydroperoxides), which are generated when PN components—particularly lipids and multivitamins—are exposed to light. These oxidants can contribute to oxidative stress and related morbidities in preterm infants.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 445, "relevance_score": 15, "raw_id": 144}}
{"sample_id": "takeoff41_145", "track": "open_ended", "split": "holdout", "question": "How do different lipid emulsions used in parenteral nutrition impact the risk of cholestatic liver disease in children, and what are the specific concerns regarding exclusive fish oil-based emulsions?", "reference_answer": "Combination emulsions have largely replaced soy-based emulsions for long-term PN because their lower phytosterol and proinflammatory ω-6 fatty acid content limits cholestatic liver disease. Exclusive fish oil-based emulsions are used to treat cholestasis due to no phytosterol content, but concerns exist regarding potential essential fatty acid deficiency because of minimal linoleic acid content.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 809, "relevance_score": 15, "raw_id": 145}}
{"sample_id": "takeoff41_146", "track": "open_ended", "split": "holdout", "question": "What criteria define 'parenteral nutrition (PN) failure' as an indication for intestinal transplantation according to the Centers for Medicare and Medicaid Services?", "reference_answer": "PN failure is defined by life-threatening complications including progressive intestinal failure–associated liver disease (IFALD), recurrent life-threatening sepsis, a single episode of fungal sepsis, or the loss of central venous access.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 822, "relevance_score": 15, "raw_id": 146}}
{"sample_id": "takeoff41_147", "track": "open_ended", "split": "holdout", "question": "Which laboratory tests are essentially monitored to identify hepatobiliary complications such as parenteral nutrition-associated liver disease (PNALD) or cholestasis in patients on long-term parenteral nutrition?", "reference_answer": "The essential laboratory tests to monitor are Gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP). Elevated levels of these cholestatic enzymes serve as clinical indicators for parenteral nutrition-associated liver disease (PNALD) or cholestasis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 78, "relevance_score": 14, "raw_id": 147}}
{"sample_id": "takeoff41_148", "track": "open_ended", "split": "holdout", "question": "In the context of long-term parenteral nutrition, what do elevated levels of Gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) typically signify?", "reference_answer": "Elevated levels of these cholestatic enzymes signal the presence of hepatobiliary complications, specifically parenteral nutrition-associated liver disease (PNALD) or cholestasis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 78, "relevance_score": 14, "raw_id": 148}}
{"sample_id": "takeoff41_149", "track": "open_ended", "split": "holdout", "question": "According to clinical management guidelines for acute episodes of MMA, what is the protocol for energy delivery and the timeline for reintroducing protein intake?", "reference_answer": "Initial management focuses on providing nonprotein energy through intravenous dextrose at a maximum glucose infusion rate (GIR) and lipids to slow catabolism. A protein source must be reintroduced within 24 to 48 hours of presentation, starting with medical foods devoid of propiogenic amino acids followed by incremental additions of standard sources to meet methionine, valine, isoleucine, and threonine requirements.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 600, "relevance_score": 14, "raw_id": 149}}
{"sample_id": "takeoff41_150", "track": "open_ended", "split": "holdout", "question": "According to evidence-based practices for neonatal nutrition, what are the typical components included in a 'starter PN' solution, and which specific electrolytes are generally excluded?", "reference_answer": "Typical starter PN solutions contain dextrose, amino acids, and calcium, and sometimes intravenous lipid emulsions (ILE). They are typically free of sodium, potassium, magnesium, and phosphorus.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 206, "relevance_score": 14, "raw_id": 150}}
{"sample_id": "takeoff41_151", "track": "open_ended", "split": "holdout", "question": "Which specific components of a parenteral nutrition solution are the primary drivers of its osmolarity, and what clinical complication must be monitored when using peripheral access?", "reference_answer": "The osmolarity of a PN solution is primarily driven by the concentrations of amino acids, dextrose, sodium, potassium, and calcium. When using peripheral access, clinicians must monitor the intravenous line site closely for signs of phlebitis or infiltration.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 152, "relevance_score": 14, "raw_id": 151}}
{"sample_id": "takeoff41_152", "track": "open_ended", "split": "holdout", "question": "What are the specific clinical indications for initiating enteral nutrition (EN) and parenteral nutrition (PN) in neonatal patients according to the provided criteria?", "reference_answer": "Indications for EN include an inability to feed by mouth, congenital malformations such as esophageal atresia/tracheoesophageal fistula, the need for airway protection, immature oral feeding skills (GA < 34 weeks), clinical status/respiratory support, insufficient oral intake to meet growth needs, oral aversion, and GI dysfunction/malabsorption. Indications for PN include congenital GI conditions or illness, clinical status requiring NPO status, inability to provide EN, or when EN is unable to meet energy expenditure and growth needs.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "Handbook", "source_file": "ASPEN_Pediatric_Neonatal_Handbook.md", "chunk_index": 183, "relevance_score": 14, "raw_id": 152}}
{"sample_id": "takeoff41_153", "track": "open_ended", "split": "holdout", "question": "How does transitioning a stable adult patient from continuous to cycled parenteral nutrition impact the risk of parenteral nutrition-associated liver disease (PNALD)?", "reference_answer": "Transitioning to cycled parenteral nutrition reduces the risk of parenteral nutrition-associated liver disease by helping to prevent hepatic cholestasis and steatosis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 288, "relevance_score": 14, "raw_id": 153}}
{"sample_id": "takeoff41_154", "track": "open_ended", "split": "holdout", "question": "What are the primary considerations for choosing a Vascular Access Device (VAD) versus a feeding tube in the management of long-term pediatric intestinal failure?", "reference_answer": "In pediatric intestinal failure, VADs are utilized for long-term parenteral nutrition (PN) when the bowel cannot meet nutritional needs, prioritizing central venous access and minimizing catheter-related bloodstream infections (CRBSIs). Feeding tubes (gastrostomy or jejunostomy) are preferred for enteral nutrition (EN) to promote gut adaptation, reduce PN dependency, and maintain mucosal integrity, provided there is sufficient intestinal length and function.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1099, "relevance_score": 14, "raw_id": 154}}
{"sample_id": "takeoff41_155", "track": "open_ended", "split": "holdout", "question": "In the context of parenteral nutrition, what clinical advantages do mixed lipid emulsions containing soybean oil, medium-chain triglycerides (MCTs), olive oil, and fish oil offer compared to traditional pure soybean oil emulsions?", "reference_answer": "Mixed lipid emulsions offer several advantages over pure soybean oil emulsions, primarily due to their balanced fatty acid profile which helps reduce oxidative stress and pro-inflammatory cytokine production. Clinically, these emulsions are associated with improved liver function and a reduced risk of parenteral nutrition-associated cholestasis (PNAC).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 93, "relevance_score": 14, "raw_id": 155}}
{"sample_id": "takeoff41_156", "track": "open_ended", "split": "holdout", "question": "Which hepatobiliary and liver enzymes are grouped together for monitoring potential parenteral nutrition-associated liver disease (PNALD) or cholestasis based on the provided clinical parameters?", "reference_answer": "The hepatobiliary and liver enzymes grouped for monitoring include AST/ALT (Aspartate Aminotransferase/Alanine Aminotransferase) and Alk Phos/GGT (Alkaline Phosphatase/Gamma-Glutamyl Transferase).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1228, "relevance_score": 14, "raw_id": 156}}
{"sample_id": "takeoff41_157", "track": "open_ended", "split": "holdout", "question": "What is the physiological reason that central venous access is preferred over peripheral access for the administration of Total Parenteral Nutrition (TPN) solutions exceeding 900 mOsm/L?", "reference_answer": "Central venous access allows for the safe infusion of hyperosmolar solutions (typically >900 mOsm/L) because the high blood flow in large central veins rapidly dilutes the solution, preventing vessel damage and reducing the risk of thrombophlebitis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 281, "relevance_score": 14, "raw_id": 157}}
{"sample_id": "takeoff41_158", "track": "open_ended", "split": "holdout", "question": "In patients receiving Parenteral Nutrition (PN), which specific trace elements and fat-soluble vitamins should be monitored every 6-12 months according to the clinical guidelines?", "reference_answer": "For patients on PN, monitoring every 6-12 months should include zinc, copper, manganese, chromium, retinol (vitamin A), vitamin D 25 hydroxy, PT/INR (vitamin K), and alpha-tocopherol (vitamin E).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 447, "relevance_score": 14, "raw_id": 158}}
{"sample_id": "takeoff41_159", "track": "open_ended", "split": "holdout", "question": "What is the common clinical practice regarding nutritional support for preterm infants during the 24 to 48-hour window surrounding a blood transfusion?", "reference_answer": "To mitigate the risk of necrotizing enterocolitis (NEC), some clinicians will hold enteral feedings and provide parenteral nutrition (PN) support for 24 to 48 hours during the transfusion period.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1138, "relevance_score": 14, "raw_id": 159}}
{"sample_id": "takeoff41_160", "track": "open_ended", "split": "holdout", "question": "Based on the findings of Dugan, Le, and Jew regarding peripheral parenteral nutrition (PN) in pediatric patients, what is the maximum tolerated osmolarity for peripheral administration?", "reference_answer": "The study by Dugan et al. investigated the maximum tolerated osmolarity for peripheral administration of parenteral nutrition in pediatric patients, which is generally recommended to be limited to 900 mOsm/L to reduce the risk of phlebitis, though some pediatric practices may vary under specific monitoring.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1106, "relevance_score": 14, "raw_id": 160}}
{"sample_id": "takeoff41_161", "track": "open_ended", "split": "holdout", "question": "In a patient receiving Total Parenteral Nutrition (TPN) who demonstrates improved oral intake and expresses a desire to return to regular meals, what is the clinically recommended next step regarding their nutrition support?", "reference_answer": "The best course of action is to reassess the patient's parenteral nutrition needs and initiate tapering of the TPN as meaningful oral nutrition is established.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 227, "relevance_score": 14, "raw_id": 161}}
{"sample_id": "takeoff41_162", "track": "open_ended", "split": "holdout", "question": "In pediatric patients receiving parenteral nutrition, how does the presence of cholestasis influence the monitoring and levels of specific trace minerals like copper and manganese?", "reference_answer": "There is a significant correlation between cholestasis and elevated serum copper and whole-blood manganese levels because these trace minerals are primarily excreted via the biliary system; monitoring and adjustment of these elements are recommended in cholestatic infants to prevent toxicity (McMillan et al., 2008 and Corkins et al., 2013).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1220, "relevance_score": 14, "raw_id": 162}}
{"sample_id": "takeoff41_163", "track": "open_ended", "split": "holdout", "question": "What does the Cochrane review by Quigley et al. suggest regarding the use of formula versus donor breast milk for feeding preterm or low birth weight infants?", "reference_answer": "The Cochrane review (Quigley et al., 2018) evaluates the clinical outcomes of formula versus donor breast milk, focusing on growth rates and the risk of significant morbidities such as necrotizing enterocolitis (NEC). It generally notes that while donor milk reduces the risk of NEC, formula-fed infants often show higher rates of short-term weight gain and linear growth.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 298, "relevance_score": 14, "raw_id": 163}}
{"sample_id": "takeoff41_164", "track": "open_ended", "split": "holdout", "question": "In the context of parenteral nutrition (PN), what clinical advantage does favoring sodium phosphate over potassium phosphate offer regarding trace element exposure and prescription simplification?", "reference_answer": "Limiting phosphate to the sodium phosphate salt form is recommended where clinically appropriate because it contains approximately 3 times less aluminum than potassium phosphate, thereby reducing aluminum exposure.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 317, "relevance_score": 13, "raw_id": 164}}
{"sample_id": "takeoff41_165", "track": "open_ended", "split": "holdout", "question": "What is the clinical significance of monitoring daily weight and serum electrolytes (Sodium, Potassium, Chloride, and Bicarbonate) in patients receiving nutrition support?", "reference_answer": "Daily weight monitoring is essential for assessing fluid status (detecting edema or dehydration) and tracking the efficacy of nutritional intake. Serum electrolytes like Sodium, Potassium, Chloride, and Bicarbonate must be monitored to identify and correct imbalances, prevent Refeeding Syndrome, and ensure acid-base homeostasis, especially during transition to parenteral or enteral nutrition.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1227, "relevance_score": 13, "raw_id": 165}}
{"sample_id": "takeoff41_166", "track": "open_ended", "split": "holdout", "question": "In pediatric patients undergoing medical nutrition therapy for a milk allergy, which specific micronutrients are most at risk of deficiency, and what are the recommended food substitutes to mitigate these risks?", "reference_answer": "The micronutrients provided by milk include Vitamin A, B1, B2 (riboflavin), B12, D, B5 (pantothenic acid), calcium, magnesium, selenium, zinc, potassium, and phosphorus. Appropriate food substitutes to mitigate these risks include meats, legumes, whole grains, nuts, mushrooms, fish, bright yellow and orange vegetables, and fortified foods or beverages specifically enriched with B vitamins, calcium, and vitamin D.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 549, "relevance_score": 13, "raw_id": 166}}
{"sample_id": "takeoff41_167", "track": "open_ended", "split": "holdout", "question": "What physiological risks and clinical parameters must be monitored when infant formula is concentrated to levels exceeding 24 kcal/oz?", "reference_answer": "When formula is concentrated to >24 kcal/oz, potential renal solute load (PRSL) must be considered because protein, sodium, chloride, potassium, and phosphorus increase PRSL, which can lead to rapid dehydration. Additionally, medical professionals must monitor the increased osmolarity of the formula, the patient's tolerance, and their fluid status.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 324, "relevance_score": 13, "raw_id": 167}}
{"sample_id": "takeoff41_168", "track": "open_ended", "split": "holdout", "question": "What strategy is suggested to simplify prescriptions and help reduce the aluminum content for patients receiving Parenteral Nutrition (PN)?", "reference_answer": "Providing potassium as a single salt form (e.g., potassium chloride) should be considered, while providing phosphate as sodium phosphate and adjusting the sodium chloride/sodium acetate ratio to meet other electrolyte needs.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 318, "relevance_score": 13, "raw_id": 168}}
{"sample_id": "takeoff41_169", "track": "open_ended", "split": "holdout", "question": "What are the specific clinical features associated with pediatric or adult patients who are successfully weaned from parenteral nutrition (PN) following significant bowel resection?", "reference_answer": "Successful weaning from PN is associated with the presence of the ileocecal valve, an intact colon, a remnant small bowel length greater than 15 cm, and the small intestine being in continuity with the colon. Additionally, the absence of clinical jaundice or cholestasis is a key indicator of potential weaning success.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 805, "relevance_score": 13, "raw_id": 169}}
{"sample_id": "takeoff41_170", "track": "open_ended", "split": "holdout", "question": "In pediatric patients receiving parenteral nutrition (PN), what specific direct bilirubin threshold may necessitate earlier monitoring of copper and manganese, and what is the physiological rationale for this adjustment?", "reference_answer": "A direct bilirubin level >2 mg/dL may prompt earlier monitoring because the biliary tract serves as the primary excretory pathway for copper and manganese, potentially leading to accumulation during cholestasis.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1204, "relevance_score": 13, "raw_id": 170}}
{"sample_id": "takeoff41_171", "track": "open_ended", "split": "holdout", "question": "What are the specific clinical indications mention in the text for initiating parenteral nutrition in pediatric oncology patients, and what complication must be monitored during advancement?", "reference_answer": "Parenteral nutrition may be necessary when children are unable to consume adequate calories for multiple days due to uncontrollable vomiting, typhlitis, severe mucositis, or intestinal obstruction. Clinicians must closely monitor for refeeding syndrome during the advancement of nutrition support, especially in patients with compromised nutrition status prior to initiation.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 887, "relevance_score": 13, "raw_id": 171}}
{"sample_id": "takeoff41_172", "track": "open_ended", "split": "holdout", "question": "At what enteral intake volume should Parenteral Nutrition (PN) be discontinued in preterm infants, and why is human milk the preferred source for enteral nutrition?", "reference_answer": "Parenteral nutrition should be reduced and eventually discontinued when enteral intake reaches volumes of 80–100 mL/kg/d. Human milk is preferred due to its multiple benefits, including trophic effects on the immature gastrointestinal tract.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1009, "relevance_score": 13, "raw_id": 172}}
{"sample_id": "takeoff41_173", "track": "open_ended", "split": "holdout", "question": "Why is peripheral parenteral nutrition (PPN) inappropriate for a critically ill patient who requires fluid restriction and high osmolarity parenteral nutrition solutions?", "reference_answer": "PPN is generally inappropriate for such patients because the high osmolarity required for concentrated nutrition can cause phlebitis in peripheral veins, and PPN typically requires larger fluid volumes to dilute the osmolarity, which is contraindicated in fluid-restricted patients.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 297, "relevance_score": 13, "raw_id": 173}}
{"sample_id": "takeoff41_174", "track": "open_ended", "split": "holdout", "question": "Which specific salt of calcium is generally preferred in Parenteral Nutrition (PN) admixtures to minimize the risk of precipitation with phosphate ions, and why?", "reference_answer": "Calcium gluconate is preferred over calcium chloride because it is less dissociated, meaning fewer free calcium ions are available to react with phosphate, thereby reducing the risk of calcium phosphate precipitation.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "NBNSC Book parsed", "source_file": "NBNSC_Book.md", "chunk_index": 80, "relevance_score": 13, "raw_id": 174}}
{"sample_id": "takeoff41_175", "track": "open_ended", "split": "holdout", "question": "According to the ASPEN Consensus Recommendations for Refeeding Syndrome, what are the primary clinical indicators and management strategies for identifying and treating this condition in malnourished patients?", "reference_answer": "Refeeding syndrome is characterized by severe electrolyte shifts (specifically phosphorus, magnesium, and potassium) and fluid imbalances that occur when nutrition is reintroduced to a malnourished patient. Management involves identifying high-risk patients, initiating nutrition slowly (often starting at 10-20 kcal/kg), and closely monitoring/replacing electrolytes before and during the refeeding process.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 520, "relevance_score": 13, "raw_id": 175}}
{"sample_id": "takeoff41_176", "track": "open_ended", "split": "holdout", "question": "In the management of parenteral nutrition-associated cholestasis, what is considered the most effective intervention to stimulate hepatobiliary secretions and promote resolution?", "reference_answer": "The most effective intervention is the initiation of enteral feedings. Conversely, providing excessive calories from lipids and carbohydrates is recognized as a provocateur of cholestasis, while the cycling of parenteral nutrition (PN) may also be used to reduce it.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 986, "relevance_score": 13, "raw_id": 176}}
{"sample_id": "takeoff41_177", "track": "open_ended", "split": "holdout", "question": "What are the typical dextrose concentration ranges for peripheral parenteral nutrition (PPN) versus central parenteral nutrition (PN) in pediatric patients as specified in clinical guidelines?", "reference_answer": "Dextrose concentrations for pediatric patients range from 10% to 12.5% for peripheral parenteral nutrition (PPN) and up to 25% or higher for central parenteral nutrition (PN).", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1146, "relevance_score": 13, "raw_id": 177}}
{"sample_id": "takeoff41_178", "track": "open_ended", "split": "holdout", "question": "What are the clinical considerations regarding the prophylactic administration of L-carnitine in the parenteral nutrition of extremely preterm infants?", "reference_answer": "While carnitine plays a role in fatty acid metabolism, systematic reviews of prophylactic L-carnitine administration in extremely preterm infants (Olid et al., 2018) and pediatric nutrition reviews (Crill & Helms, 2007) evaluate its necessity in improving lipid tolerance and growth, though routine supplementation remains a subject of ongoing clinical debate.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Pediatric_Nutrition", "source_file": "ASPEN_Pediatric_Nutrition.md", "chunk_index": 1220, "relevance_score": 13, "raw_id": 178}}
{"sample_id": "takeoff41_179", "track": "open_ended", "split": "holdout", "question": "According to clinical guidelines for parenteral nutrition (PN) management, what are the specific interventions for PN-related cholestasis and the target goal for urinary sodium?", "reference_answer": "In the case of PN-related cholestasis, manganese should be removed and copper provision should be decreased by half. The goal for urinary sodium is >30 mEq/L, with PN sodium provision titrated accordingly.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 444, "relevance_score": 13, "raw_id": 179}}
{"sample_id": "takeoff41_180", "track": "open_ended", "split": "holdout", "question": "According to clinical guidelines for refeeding syndrome, which baseline laboratory markers must be obtained and corrected prior to the initiation or advancement of nutrition support?", "reference_answer": "Baseline refeeding labs including potassium (K), phosphorus (Phos), and magnesium (Mg) must be obtained and any abnormalities corrected before initiating or advancing nutrition, including dextrose-containing IV fluids, oral, enteral, or parenteral nutrition.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 370, "relevance_score": 13, "raw_id": 180}}
{"sample_id": "takeoff41_181", "track": "open_ended", "split": "holdout", "question": "What factors must be excluded to ensure a patient's potassium level is not artificially elevated, and what initial laboratory tests are recommended for the assessment of hyperkalemia?", "reference_answer": "To ensure the potassium level is not artificially elevated, clinicians must exclude pseudohyperkalemia caused by traumatic blood draws, leukocytosis, thrombocytosis, hemolyzed samples, or infusions/parenteral nutrition administered through the same line. Recommended initial laboratory tests include a basic metabolic profile, serum magnesium, serum calcium, BUN, serum creatinine, serum phosphorus, complete blood count, and serum glucose.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 106, "relevance_score": 13, "raw_id": 181}}
{"sample_id": "takeoff41_182", "track": "open_ended", "split": "holdout", "question": "What electrolyte abnormalities are most characteristic of Refeeding Syndrome, and how should clinical practitioners adjust initial caloric intake to mitigate this risk?", "reference_answer": "Refeeding Syndrome is characterized by significant shifts in electrolytes, most notably hypophosphatemia, hypokalemia, and hypomagnesemia. To mitigate risk, evidence-based practices suggest initiating nutrition at a reduced caloric level (e.g., 10–20 kcal/kg or roughly 25% of estimated needs) and slowly advancing over 3 to 5 days while closely monitoring and replacing electrolytes.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 26, "relevance_score": 13, "raw_id": 182}}
{"sample_id": "takeoff41_183", "track": "open_ended", "split": "holdout", "question": "According to the systematic review by Rocks T et al. (2014), what is the evidence regarding nutrition therapy during the initiation of refeeding in underweight children and adolescent inpatients with Anorexia Nervosa?", "reference_answer": "The systematic review by Rocks T et al. (2014) indicates that while traditional approaches favored cautious refeeding starting at low caloric levels, more recent evidence suggest that higher calorie refeeding (starting at 1,200 to 1,500 kcal/day or higher) may be safe and effective for undernourished adolescents with Anorexia Nervosa when accompanied by close medical monitoring of electrolytes to prevent refeeding syndrome.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 426, "relevance_score": 11, "raw_id": 183}}
{"sample_id": "takeoff41_184", "track": "open_ended", "split": "holdout", "question": "List the essential assessment and determination steps required to develop a parenteral nutrition plan before the infusion begins.", "reference_answer": "The initiation steps include: assessing nutritional status (growth, GI, and deficiency history); determining the appropriate weight for calculations; identifying the type of intravenous access; determining fluid requirements and any restrictions; establishing macronutrient initial needs and goals (calories, protein, fat, carbohydrates); and determining the duration and infusion rates for both PN and lipids.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 335, "relevance_score": 11, "raw_id": 184}}
{"sample_id": "takeoff41_185", "track": "open_ended", "split": "holdout", "question": "Which various electrolyte imbalances and clinical syndromes are associated with the development of cardiac arrhythmias according to the provided text?", "reference_answer": "Cardiac arrhythmias are associated with diabetic ketoacidosis (DKA), hyperkalemia (especially in renal failure), hypocalcemia, hypokalemia, hypomagnesemia, hypophosphatemia, metabolic acidosis, and refeeding syndrome.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 363, "relevance_score": 11, "raw_id": 185}}
{"sample_id": "takeoff41_186", "track": "open_ended", "split": "holdout", "question": "According to evidence-based practices for high-output ileostomies (>1 L/d), what nutritional and medical strategies should be implemented to minimize ostomy effluent and manage acid-base disturbances?", "reference_answer": "Management should include patient education on consuming small frequent meals and avoiding disaccharides to reduce osmotic load. Fluid replacement should approximate the electrolyte composition of ileal fluid, and antidiarrheal agents should be used as needed. If high output and weight loss persist, parenteral nutrition (PN) may be indicated.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 252, "relevance_score": 11, "raw_id": 186}}
{"sample_id": "takeoff41_187", "track": "open_ended", "split": "holdout", "question": "What respiratory complication can occur in patients with severe hypophosphatemia during the institution of enteral or parenteral nutrition, as cited in clinical reports?", "reference_answer": "Acute respiratory failure is a documented complication associated with hypophosphatemia and refeeding syndrome following the initiation of nutritional support.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 339, "relevance_score": 11, "raw_id": 187}}
{"sample_id": "takeoff41_188", "track": "open_ended", "split": "holdout", "question": "What is the primary nutritional management strategy for an infant with an abdominal wall defect lacking a sac prior to the toleration of enteral feeds?", "reference_answer": "The primary management strategy is to provide Total Parenteral Nutrition (TPN) until the infant is surgically repaired and demonstrates tolerance to enteral feedings.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 498, "relevance_score": 11, "raw_id": 188}}
{"sample_id": "takeoff41_189", "track": "open_ended", "split": "holdout", "question": "According to the protocol for treating alcoholic and starvation ketosis, what sequence of interventions must be followed to prevent Wernicke’s encephalopathy and refeeding syndrome complications?", "reference_answer": "Thiamin supplementation must be administered prior to dextrose administration and electrolyte supplementation. This sequence is necessary to prevent Wernicke's encephalopathy, Korsakoff's syndrome, and electrolyte depletion such as hypophosphatemia, hypokalemia, and hypomagnesemia caused by refeeding syndrome.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 241, "relevance_score": 11, "raw_id": 189}}
{"sample_id": "takeoff41_190", "track": "open_ended", "split": "holdout", "question": "What is the specific caloric density of dextrose in parenteral nutrition, and what is the recommended macronutrient distribution goal for total parenteral energy intake?", "reference_answer": "Dextrose provides 3.4 kcal/g, and the recommended macronutrient distribution goal is 40-60% of total parenteral energy intake.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 339, "relevance_score": 11, "raw_id": 190}}
{"sample_id": "takeoff41_191", "track": "open_ended", "split": "holdout", "question": "What steps regarding electrolyte management and fluid balance should be taken prior to and during the initiation of nutrition support to mitigate the risk of refeeding syndrome?", "reference_answer": "Clinicians should identify at-risk patients, correct electrolyte abnormalities before starting nutrition, increase maintenance doses of phosphate, potassium, and magnesium for those with normal renal function, and consider sodium and fluid restriction for the first few days.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 322, "relevance_score": 11, "raw_id": 191}}
{"sample_id": "takeoff41_192", "track": "open_ended", "split": "holdout", "question": "According to the ASPEN Consensus Recommendations, what specific electrolyte changes characterize the onset of Refeeding Syndrome (RFS)?", "reference_answer": "Refeeding syndrome (RFS) is characterized by a measurable reduction in any combination of phosphorus, potassium, and/or magnesium levels, or the manifestation of thiamine deficiency, occurring shortly after the initiation of calories in a malnourished patient.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 371, "relevance_score": 11, "raw_id": 192}}
{"sample_id": "takeoff41_193", "track": "open_ended", "split": "holdout", "question": "Based on the Academy of Nutrition and Dietetics Pediatric Nutrition Care Manual, what specific laboratory values and clinical indicators should be monitored to assess for refeeding syndrome in a severely malnourished pediatric oncology patient?", "reference_answer": "Monitoring should include serum electrolytes (specifically phosphorus, potassium, and magnesium), blood glucose, and fluid balance (intake/output) to detect rapid intracellular shifts that occur upon reintroduction of carbohydrates.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 466, "relevance_score": 11, "raw_id": 193}}
{"sample_id": "takeoff41_194", "track": "open_ended", "split": "holdout", "question": "According to the studies by Thompson et al. (2013) and Le Palma et al. (2017), what is the clinical rationale and primary concern for the pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate) in infants with renal insufficiency?", "reference_answer": "The rationale is to treat hyperkalemia by lowering the potassium content of the milk or formula before ingestion; however, the primary concern is the high prevalence of electrolyte derangements, such as hypernatremia and hypocalcemia, that can occur in clinical practice as a result of the cation exchange.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "PEDIATRIC NUTRITION", "source_file": "Childrens_Health_Pediatric.md", "chunk_index": 511, "relevance_score": 11, "raw_id": 194}}
{"sample_id": "takeoff41_195", "track": "open_ended", "split": "holdout", "question": "What are the clinical consequences and recommended initial IV supplementation levels for phosphorus in premature neonates?", "reference_answer": "Inadequate supplementation can cause rickets and severe hypophosphatemia can lead to hypercalcemia in neonates. Supplementation for preterm neonates typically begins at 1–2.5 mmol/kg within 1–2 days.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 351, "relevance_score": 10, "raw_id": 195}}
{"sample_id": "takeoff41_196", "track": "open_ended", "split": "holdout", "question": "What physical and neurological symptoms are clinical indicators of refeeding syndrome and how does it affect metabolic acid-base balance?", "reference_answer": "Refeeding syndrome presents with neuromuscular symptoms, muscle weakness, and mental status changes. Metabolically, it can lead to both metabolic acidosis and metabolic alkalosis, and is characterized by significant shifts in electrolytes such as hypophosphatemia, which contributes to the neuromuscular clinical presentation.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 372, "relevance_score": 10, "raw_id": 196}}
{"sample_id": "takeoff41_197", "track": "open_ended", "split": "holdout", "question": "How does therapy with teduglutide affect clinical monitoring requirements for patients with gastrointestinal impairment, and within what timeframe are its effects typically observed?", "reference_answer": "Teduglutide acts as a GI trophic hormone that promotes growth and maintenance of the intestinal epithelium. Clinically, it results in gradual weight gain and increased urine output even when parenteral nutrition or IV fluid doses remain stable. These effects can be observed within 8 weeks of starting treatment, necessitating careful monitoring and reduction of fluid and electrolyte supplementation to avoid overload.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN_Fluids_Electrolytes", "source_file": "ASPEN_Fluids_Electrolytes.md", "chunk_index": 291, "relevance_score": 10, "raw_id": 197}}
{"sample_id": "takeoff41_198", "track": "open_ended", "split": "holdout", "question": "What role do lipid emulsions play in the microbial environment of total parenteral nutrition (TPN) solutions and the subsequent risk of infection for adult inpatients as noted by Kuwahara et al. (2010) and Mitsuboshi et al. (2017)?", "reference_answer": "Lipid emulsions facilitate the growth of microorganisms in TPN solutions and are associated with an increased risk of central line infection in adult inpatients.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 224, "relevance_score": 15, "raw_id": 198}}
{"sample_id": "takeoff41_199", "track": "open_ended", "split": "holdout", "question": "What have clinical studies suggested regarding the use of parenteral fish oil monotherapy in the management of parenteral nutrition-associated liver disease (PNALD)?", "reference_answer": "Studies, such as those by de Meijer et al. (2010), indicate that parenteral fish oil monotherapy can be utilized as a management strategy for patients with parenteral nutrition-associated liver disease (PNALD), often focusing on reversing cholestasis in pediatric and adult populations.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 361, "relevance_score": 15, "raw_id": 199}}
{"sample_id": "takeoff41_200", "track": "open_ended", "split": "holdout", "question": "What are the specific protein requirements and calorie targets for a patient diagnosed with Refeeding Syndrome during the initial 24-48 hours of nutritional rehabilitation?", "reference_answer": "During the initial 24–48 hours of treating Refeeding Syndrome, caloric intake should be restricted to 10–20 kcal/kg/day while protein intake is maintained to support lean body mass. Concurrently, electrolytes including phosphorus, magnesium, and potassium must be aggressively monitored and replaced.", "domain": "tpn", "proficiency": null, "source_doc": null, "page": null, "metadata": {"question_type": "open_ended", "book_title": "ASPEN Parenteral Nutrition Handbook", "source_file": "ASPEN_Parenteral_Nutrition.md", "chunk_index": 73, "relevance_score": 15, "raw_id": 200}}
